The American Journal of Cardiology
-
Publication Venue For
-
Association of Clinician Knowledge and Statin Beliefs With Statin Therapy Use and Lipid Levels (A Survey of US Practice in the PALM Registry)..
123:1011-1018.
2019
-
Effects of Exercise Training With and Without Ranolazine on Peak Oxygen Consumption, Daily Physical Activity, and Quality of Life in Patients With Chronic Stable Angina Pectoris
2019
-
Frequency of Ventricular Arrhythmias and Other Rhythm Abnormalities in Children and Young Adults With the Marfan Syndrome..
122:1429-1436.
2018
-
Renal Function and Exercise Training in AmbulatoryHeart Failure Patients With a Reduced Ejection Fraction..
122:999-1007.
2018
-
Comparison of Outcomes and Costs Associated With Aspirin ± Clopidogrel After Coronary Artery Bypass Grafting..
121:709-714.
2018
-
Usefulness of Multiple Biomarkers for Predicting Incident Major Adverse Cardiac Events in Patients Who Underwent Diagnostic Coronary Angiography (from the Catheter Sampled Blood Archive in Cardiovascular Diseases [CASABLANCA] Study)..
120:25-32.
2017
-
Body Weights in Adults With Congenital Heart Disease and the Obesity Frequency.
119:638-642.
2017
-
Anticoagulation After Heart Valve Replacement or Transcatheter Valve Implantation..
118:1419-1426.
2016
-
Electrocardiographic J Wave and Cardiovascular Outcomes in the General Population (from the Atherosclerosis Risk In Communities Study)..
118:811-815.
2016
-
Effect of a Multidisciplinary Approach for the Management of Patients With Atrial Fibrillation in the Emergency Department on Hospital Admission Rate and Length of Stay..
118:64-71.
2016
-
Comparison of Frequency of Frailty and Severely Impaired Physical Function in Patients ≥60 Years Hospitalized With Acute Decompensated Heart Failure Versus Chronic Stable Heart Failure With Reduced and Preserved Left Ventricular Ejection Fraction..
117:1953-1958.
2016
-
Geographic Differences in Patients in a Global Acute Heart Failure Clinical Trial (from the ASCEND-HF Trial)..
117:1771-1778.
2016
-
Effects of Polyunsaturated Fatty Acid Treatment on Postdischarge Outcomes After Acute Myocardial Infarction..
117:340-346.
2016
-
Temporal Changes in Postdischarge Mortality Risk After Hospitalization for Heart Failure (from the EVEREST Trial)..
117:611-616.
2016
-
Usefulness of Von Willebrand Factor Activity Indexes to Predict Therapeutic Response in Hypertrophic Cardiomyopathy..
117:436-442.
2016
-
Contemporary cardiovascular device clinical trials (trends and patterns 2001 to 2012)..
116:307-312.
2015
-
Effect of minor liver function test abnormalities and values within the normal range on survival in heart failure..
115:938-941.
2015
-
ST2 in Pulmonary Disease..
115:44B-47B.
2015
-
The International ST2 Consensus Panel: Introduction..
115:1B-2B.
2015
-
From acute decompensated to chronic heart failure..
114:1923-1929.
2014
-
Prognostic usefulness of insulin-like growth factor-binding protein 7 in heart failure with reduced ejection fraction: a novel biomarker of myocardial diastolic function?.
114:1543-1549.
2014
-
Impact of statin use on exercise-induced cardiac troponin elevations..
114:624-628.
2014
-
Comparison of the relation between left ventricular anatomy and QRS duration in patients with cardiomyopathy with versus without left bundle branch block..
113:1717-1722.
2014
-
Longitudinal follow-up of implantable cardioverter defibrillator leads..
113:103-106.
2014
-
Impact of Aortic Valve Replacement for Aortic Stenosis on Dynamic Mitral Annular Motion and Geometry.
112:1445-1449.
2013
-
Emergency room and inpatient use after cardiac pacemaker implantation..
111:563-568.
2013
-
Indexes of von Willebrand factor as biomarkers of aortic stenosis severity (from the Biomarkers of Aortic Stenosis Severity [BASS] study)..
111:374-381.
2013
-
Prognostic value of monocyte count in patients hospitalized for heart failure with reduced ejection fraction (from the EVEREST Trial)..
110:1657-1662.
2012
-
Left circumflex occlusion in acute myocardial infarction (from the National Cardiovascular Data Registry)..
108:959-963.
2011
-
Reply.
107:143-144.
2011
-
patient and practice factors associated with improvement in use of guideline-recommended therapies for outpatients with heart failure (from the IMPROVE HF trial)..
107:250-258.
2011
-
Reply.
106:601-602.
2010
-
Incidence, Clinical Presentation and Outcomes of Drug-Eluting Stent Associated Coronary Aneurysms - a Pooled Analysis.
104:144D-144D.
2009
-
Incidence and predictors of stroke associated with percutaneous coronary intervention..
104:349-353.
2009
-
Characteristics and in-hospital outcomes of patients with cardiac tamponade complicating type A acute aortic dissection..
103:1029-1031.
2009
-
Defining optimal research study design for cardiovascular imaging using computed tomography angiography as a model..
102:943-948.
2008
-
Perioperative bridging therapy with unfractionated heparin or low-molecular-weight heparin in patients with mechanical prosthetic heart valves on long-term oral anticoagulants (from the REGIMEN Registry)..
102:883-889.
2008
-
Reproducibility of peak oxygen uptake and other cardiopulmonary exercise testing parameters in patients with heart failure (from the Heart Failure and A Controlled Trial Investigating Outcomes of exercise traiNing)..
102:712-717.
2008
-
Weekend/holiday versus weekday hospital discharge and guideline adherence (from the American Heart Association's Get with the Guidelines--Coronary Artery Disease database)..
102:663-667.
2008
-
Implementing critical pathways and a multidisciplinary team approach to cardiovascular disease management..
102:47G-56G.
2008
-
Hepatocellular carcinoma with intracavitary cardiac involvement: a case report and review of the literature..
102:643-645.
2008
-
Impact of perioperative myocardial infarction on angiographic and clinical outcomes following coronary artery bypass grafting (from PRoject of Ex-vivo Vein graft ENgineering via Transfection [PREVENT] IV)..
102:546-551.
2008
-
Is coding for myocardial infarction more accurate now that coding descriptions have been clarified to distinguish ST-elevation myocardial infarction from non-ST elevation myocardial infarction?.
102:513-517.
2008
-
Outcomes of patients with acute coronary syndrome and previous coronary artery bypass grafting (from the Pravastatin or Atorvastatin Evaluation and Infection Therapy [PROVE IT-TIMI 22] and the Aggrastat to Zocor [A to Z] trials)..
102:552-558.
2008
-
The editor's roundtable: lipid management beyond statins-reducing residual cardiovascular risk..
102:559-567.
2008
-
Emerging role of myocardial perfusion imaging to evaluate patients for cardiac resynchronization therapy..
102:211-217.
2008
-
Indian poverty and cardiovascular disease..
102:102-106.
2008
-
Risk prediction of coronary heart disease based on retinal vascular caliber (from the Atherosclerosis Risk In Communities [ARIC] Study)..
102:58-63.
2008
-
The editor's roundtable: B-type natriuretic peptide..
101:1733-1740.
2008
-
The editor's roundtable: management and treatment of non-ST-segment elevation in acute coronary syndromes..
101:1580-1598.
2008
-
Impact of home warfarin use on the treatment and outcomes of patients undergoing percutaneous coronary intervention..
101:1413-1417.
2008
-
Influence of the timing of cardiac catheterization and the amount of contrast media on acute renal failure after cardiac surgery..
101:1112-1118.
2008
-
Rhythm versus rate control in the contemporary management of atrial fibrillation in-hospital..
101:1134-1141.
2008
-
Comparison of renal function and cardiovascular risk following acute myocardial infarction in patients with and without diabetes mellitus..
101:925-929.
2008
-
Usefulness of quantitative versus qualitative ST-segment depression for risk stratification of non-ST elevation acute coronary syndromes in contemporary clinical practice..
101:919-924.
2008
-
Usefulness of right ventricular fractional area change to predict death, heart failure, and stroke following myocardial infarction (from the VALIANT ECHO Study)..
101:607-612.
2008
-
Meta-analysis comparing reported frequency of atrial fibrillation after acute coronary syndromes in Asians versus whites..
101:506-509.
2008
-
Amino-terminal pro-B-type natriuretic peptide testing and prognosis in patients with acute dyspnea, including those with acute heart failure..
101:49-55.
2008
-
Amino-terminal pro-B-type natriuretic peptide testing for inpatient monitoring and treatment guidance of acute destabilized heart failure..
101:67-71.
2008
-
Amino-terminal pro-B-type natriuretic peptide testing for the diagnosis or exclusion of heart failure in patients with acute symptoms..
101:29-38.
2008
-
Biology of the natriuretic peptides..
101:3-8.
2008
-
Importance and interpretation of intermediate (gray zone) amino-terminal pro-B-type natriuretic peptide concentrations..
101:39-42.
2008
-
The differential diagnosis of an elevated amino-terminal pro-B-type natriuretic peptide level..
101:43-48.
2008
-
Understanding amino-terminal pro-B-type natriuretic peptide in obesity..
101:89-94.
2008
-
Factors associated with off-label use of drug-eluting stents in patients with ST-elevation myocardial infarction..
101:286-292.
2008
-
Relation of low hemoglobin and anemia to morbidity and mortality in patients hospitalized with heart failure (insight from the OPTIMIZE-HF registry)..
101:223-230.
2008
-
International variation in the use of blood transfusion in patients with non-ST-segment elevation acute coronary syndromes..
101:25-29.
2008
-
Cannabinoid-1 receptor blockade in cardiometabolic risk reduction: safety, tolerability, and therapeutic potential..
100:27P-32P.
2007
-
Exercise training amount and intensity effects on metabolic syndrome (from Studies of a Targeted Risk Reduction Intervention through Defined Exercise)..
100:1759-1766.
2007
-
Patterns and implications of B-type natriuretic peptide measurement in patients with non-ST-segment elevation acute coronary syndromes..
100:1727-1733.
2007
-
Clinical and angiographic correlates of short- and long-term mortality in patients undergoing coronary artery bypass grafting..
100:1538-1542.
2007
-
Effectiveness and safety of reduced-dose enoxaparin in non-ST-segment elevation acute coronary syndrome followed by antiplatelet therapy alone for percutaneous coronary intervention..
100:1376-1382.
2007
-
Medical therapies and invasive treatments for coronary artery disease by body mass: the "obesity paradox" in the Get With The Guidelines database..
100:1331-1335.
2007
-
Rapid assay brain natriuretic peptide and troponin I in patients hospitalized with decompensated heart failure (from the Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness Trial)..
100:1427-1433.
2007
-
Usefulness of aminoterminal pro-brain natriuretic peptide testing for the diagnostic and prognostic evaluation of dyspneic patients with diabetes mellitus seen in the emergency department (from the PRIDE Study)..
100:1336-1340.
2007
-
Antiplatelet therapy after implantation of drug-eluting stents: duration, resistance, alternatives, and management of surgical patients..
100:18M-25M.
2007
-
The relation between clinical features, angiographic findings, and the target lesion revascularization rate in patients receiving the endeavor zotarolimus-eluting stent for treatment of native coronary artery disease: an analysis of ENDEAVOR I, ENDEAVOR II, ENDEAVOR II Continued Access Registry, and ENDEAVOR III..
100:62M-70M.
2007
-
Impact of delay in door-to-needle time on mortality in patients with ST-segment elevation myocardial infarction..
100:1227-1232.
2007
-
Effect of intensive lipid-lowering therapy on mortality after acute coronary syndrome (a patient-level analysis of the Aggrastat to Zocor and Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 trials)..
100:1047-1051.
2007
-
Ethnic differences in coronary artery calcium in a healthy cohort aged 60 to 69 years..
100:981-985.
2007
-
Racial disparity in the utilization of implantable-cardioverter defibrillators among patients with prior myocardial infarction and an ejection fraction of .
100:924-929.
2007
-
The Editor's Roundtable: arterial thrombosis and acute coronary syndromes..
100:974-980.
2007
-
Diagnostic usefulness and prognostic implications of the mitral E/E' ratio in patients with heart failure and severe secondary mitral regurgitation..
100:860-865.
2007
-
Comparison of baseline characteristics, treatment patterns, and in-hospital outcomes of Asian versus non-Asian white Americans with non-ST-segment elevation acute coronary syndromes from the CRUSADE quality improvement initiative..
100:391-396.
2007
-
Comparison of survival among patients with connective tissue disease and cardiomyopathy (systemic sclerosis, systemic lupus erythematosus, and undifferentiated disease)..
100:513-517.
2007
-
Utility of tissue Doppler and strain echocardiography in arrhythmogenic right ventricular dysplasia/cardiomyopathy..
100:507-512.
2007
-
Comparison of myocardial reperfusion in patients undergoing percutaneous coronary intervention in ST-segment elevation acute myocardial infarction with versus without diabetes mellitus (from the EMERALD Trial)..
100:206-210.
2007
-
Differences between local hospital and core laboratory interpretation of the admission electrocardiogram in patients with acute coronary syndromes and their relation to outcome..
100:169-174.
2007
-
Designation and distribution of events in the Multicenter UnSustained Tachycardia Trial (MUSTT)..
100:76-83.
2007
-
Evolving role of multidetector computed tomography in evaluation of arrhythmogenic right ventricular dysplasia/cardiomyopathy..
100:99-105.
2007
-
Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial: Design and methods.
99.
2007
-
Glycemia treatment strategies in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial..
99:34i-43i.
2007
-
Impact of time to treatment on myocardial reperfusion and infarct size with primary percutaneous coronary intervention for acute myocardial infarction (from the EMERALD Trial)..
99:1680-1686.
2007
-
A comparison by medicine residents of physical examination versus hand-carried ultrasound for estimation of right atrial pressure..
99:1614-1616.
2007
-
Patterns of aspirin dosing in non-ST-elevation acute coronary syndromes in the CRUSADE Quality Improvement Initiative..
99:1496-1499.
2007
-
Heart failure with preserved left ventricular systolic function among patients with non-ST-segment elevation acute coronary syndromes..
99:1351-1356.
2007
-
Timing of glycoprotein IIb/IIIa inhibitor use and outcomes among patients with non-ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention (results from CRUSADE)..
99:1389-1393.
2007
-
Changes in patterns of coronary revascularization strategies for patients with acute coronary syndromes (from the CRUSADE Quality Improvement Initiative)..
99:1222-1226.
2007
-
Comparison of in-hospital outcomes of patients with versus without previous carotid endarterectomy undergoing carotid stenting (from the German ALKK CAS Registry)..
99:1288-1293.
2007
-
Comparisons of guideline-recommended therapies in patients with documented coronary artery disease having percutaneous coronary intervention versus coronary artery bypass grafting versus medical therapy only (from the REACH International Registry)..
99:1212-1215.
2007
-
Relation between number of component views and accuracy of left ventricular mass determined by three-dimensional echocardiography..
99:1321-1324.
2007
-
Impact of baseline platelet count in patients undergoing primary percutaneous coronary intervention in acute myocardial infarction (from the CADILLAC trial)..
99:1055-1061.
2007
-
Relation between leucocyte count, myonecrosis, myocardial perfusion, and outcomes following primary angioplasty..
99:1067-1071.
2007
-
Usefulness of ST depression with T-wave inversion in leads V(4) to V(6) for predicting one-year mortality in non-ST-elevation acute coronary syndrome (from the Electrocardiographic Analysis of the Global Use of Strategies to Open Occluded Coronary Arteries IIB Trial)..
99:934-938.
2007
-
Efficacy of drug therapy in the secondary prevention of cardiovascular disease and stroke..
99:1E-35E.
2007
-
Safety considerations with gastrointestinally active lipid-lowering drugs..
99:47C-55C.
2007
-
Safety considerations with niacin therapy..
99:22C-31C.
2007
-
Effect of anger provocation on endothelium-dependent and -independent vasodilation..
99:860-863.
2007
-
Impact of initial heart rate and systolic blood pressure on relation of age and mortality among fibrinolytic-treated patients with acute ST-elevation myocardial infarction presenting with cardiogenic shock..
99:793-796.
2007
-
Exercise-induced hypertension, endothelial dysfunction, and coronary artery disease in a marathon runner..
99:743-744.
2007
-
Role of lifestyle and oral anti-diabetic agents to prevent type 2 diabetes mellitus and cardiovascular disease..
99:726-731.
2007
-
Protection of Distal Embolization in High-Risk Patients with Acute ST-Segment Elevation Myocardial Infarction (PREMIAR)..
99:357-363.
2007
-
Racial differences among high-risk patients presenting with non-ST-segment elevation acute coronary syndromes (results from the SYNERGY trial)..
99:315-321.
2007
-
Trends in operator and hospital procedure volume and outcomes for percutaneous transluminal coronary angioplasty, 1996 to 2001..
99:339-343.
2007
-
Comparison of effectiveness of enoxaparin versus unfractionated heparin to reduce silent and clinically apparent acute myocardial infarction in patients presenting with non-ST-segment elevation acute coronary syndrome..
99:186-188.
2007
-
Usefulness of routine unfractionated heparin infusion following primary percutaneous coronary intervention for acute myocardial infarction in patients not receiving glycoprotein IIb/IIIa inhibitors..
99:202-207.
2007
-
Financial implications of a model heart failure disease management program for providers, hospital, healthcare systems, and payer perspectives..
99:256-260.
2007
-
Patterns of guideline adherence and care delivery for patients with unstable angina and non-ST-segment elevation myocardial infarction (from the CRUSADE Quality Improvement Initiative)..
98:30Q-35Q.
2006
-
Periannular complications in infective endocarditis involving native aortic valves..
98:1254-1260.
2006
-
Periannular complications in infective endocarditis involving prosthetic aortic valves..
98:1261-1268.
2006
-
Temporal trends in the use of early cardiac catheterization in patients with non-ST-segment elevation acute coronary syndromes (results from CRUSADE)..
98:1172-1176.
2006
-
Cost-effectiveness of using N-terminal pro-brain natriuretic peptide to guide the diagnostic assessment and management of dyspneic patients in the emergency department..
98:800-805.
2006
-
Evaluation of the National Cholesterol Education Program Adult Treatment Panel III algorithm for selecting candidates for statin therapy: insights from the A to Z trial..
98:739-742.
2006
-
Challenges in predicting the need for coronary artery bypass grafting at presentation in patients with non-ST-segment elevation acute coronary syndromes..
98:624-627.
2006
-
Comparative early and late outcomes after primary percutaneous coronary intervention in ST-segment elevation and non-ST-segment elevation acute myocardial infarction (from the CADILLAC trial)..
98:331-337.
2006
-
Prevalence and predictors of angina pectoris one month after myocardial infarction..
98:282-288.
2006
-
Recognition and treatment of depression and anxiety in patients with acute myocardial infarction..
98:319-324.
2006
-
Usefulness of intermediate amino-terminal pro-brain natriuretic peptide concentrations for diagnosis and prognosis of acute heart failure..
98:386-390.
2006
-
From vulnerable plaque to vulnerable patient--Part III: Executive summary of the Screening for Heart Attack Prevention and Education (SHAPE) Task Force report..
98:2H-15H.
2006
-
Efficacy of azimilide for the maintenance of sinus rhythm in patients with paroxysmal atrial fibrillation in the presence and absence of structural heart disease..
98:215-218.
2006
-
Prognosis of patients taking selective serotonin reuptake inhibitors before coronary artery bypass grafting..
98:42-47.
2006
-
Impact of congestive heart failure in patients with non-ST-segment elevation acute coronary syndromes..
97:1707-1712.
2006
-
Relation of ventricular premature complexes during recovery from a myocardial perfusion exercise stress test to myocardial ischemia..
97:1570-1572.
2006
-
Cardiovascular disease risk stratification with stress single-photon emission computed tomography technetium-99m tetrofosmin imaging in patients with the metabolic syndrome and diabetes mellitus..
97:1538-1544.
2006
-
Comparison of long-term (seven year) outcomes among patients undergoing percutaneous coronary revascularization with versus without stenting..
97:1467-1472.
2006
-
On- versus off-label use of drug-eluting coronary stents in clinical practice (report from the American College of Cardiology National Cardiovascular Data Registry [NCDR])..
97:1478-1481.
2006
-
Retinal arterial signs and coronary heart disease..
97:1549.
2006
-
Benefit versus risk in statin treatment..
97:95C-97C.
2006
-
Final conclusions and recommendations of the National Lipid Association Statin Safety Assessment Task Force..
97:89C-94C.
2006
-
Statin safety: an assessment using an administrative claims database..
97:61C-68C.
2006
-
Proportion of patients followed in a specialized heart failure clinic needing an implantable cardioverter defibrillator as determined by applying different trial eligibility criteria..
97:882-885.
2006
-
Feasibility and variability of three dimensional echocardiography in arrhythmogenic right ventricular dysplasia/cardiomyopathy..
97:703-709.
2006
-
Frequency and consequences of recording an electrocardiogram >10 minutes after arrival in an emergency room in non-ST-segment elevation acute coronary syndromes (from the CRUSADE Initiative)..
97:437-442.
2006
-
Patterns and predictors of warfarin use in patients with new-onset atrial fibrillation from the FRACTAL Registry..
97:538-543.
2006
-
Usefulness of biomarkers for predicting long-term mortality in patients with diabetes mellitus and non-ST-elevation acute coronary syndromes (a GUSTO IV substudy)..
97:167-172.
2006
-
Implications of periaortic hematoma in patients with acute aortic dissection (from the International Registry of Acute Aortic Dissection)..
96:1734-1738.
2005
-
Outcomes of patients consented but not randomized in a trial of primary percutaneous coronary intervention in acute myocardial infarction (the CADILLAC registry)..
96:1649-1655.
2005
-
Impact of bleeding severity on clinical outcomes among patients with acute coronary syndromes..
96:1200-1206.
2005
-
Relation of early saphenous vein graft failure to outcomes following coronary artery bypass surgery..
96:1254-1259.
2005
-
Clinical characteristics and outcome of aortic endocarditis with periannular abscess in the International Collaboration on Endocarditis Merged Database..
96:976-981.
2005
-
In-hospital revascularization and one-year outcome of acute coronary syndrome patients stratified by the GRACE risk score..
96:913-916.
2005
-
Outcomes by race and etiology of patients with left ventricular systolic dysfunction..
96:956-963.
2005
-
Short- and long-term outcomes of patients with electrocardiographic left ventricular hypertrophy after fibrinolysis for acute myocardial infarction..
96:1050-1052.
2005
-
Treating patients with acute coronary syndromes with aggressive antiplatelet therapy (from the Global Registry of Acute Coronary Events)..
96:917-921.
2005
-
Overview of current noninodilator therapies for acute heart failure syndromes..
96:41G-46G.
2005
-
The Pilot Randomized Study of Nesiritide Versus Dobutamine in Heart Failure (PRESERVD-HF)..
96:18G-25G.
2005
-
Effects of beta-blockers on implantable cardioverter defibrillator therapy and survival in the patients with ischemic cardiomyopathy (from the Multicenter Automatic Defibrillator Implantation Trial-II)..
96:691-695.
2005
-
Frequency, predictors, and outcomes of drug-eluting stent utilization in patients with high-risk non-ST-segment elevation acute coronary syndromes..
96:750-755.
2005
-
Impact of in-hospital acquired thrombocytopenia in patients undergoing primary angioplasty for acute myocardial infarction..
96:474-481.
2005
-
Risk factors for cerebrovascular events following fontan palliation in patients with a functional single ventricle..
96:587-591.
2005
-
Comparison of the five-electrode-derived EASI electrocardiogram to the Mason Likar electrocardiogram in the prehospital setting..
96:453-456.
2005
-
Impact and determinants of left ventricular function in patients undergoing primary percutaneous coronary intervention in acute myocardial infarction..
96:325-331.
2005
-
Atherosclerotic risk genotypes and recurrent coronary events after myocardial infarction..
96:177-182.
2005
-
Combined use of amino terminal-pro-brain natriuretic peptide levels and QRS duration to predict left ventricular systolic dysfunction in patients with dyspnea..
96:263-266.
2005
-
Electrocardiographic findings over time in arrhythmogenic right ventricular dysplasia/cardiomyopathy..
96:122-126.
2005
-
Hostility, age, and mortality in a sample of cardiac patients..
96:64-66.
2005
-
Characterization of myocardial infarction as an end point in two large trials of acute coronary syndromes..
95:1404-1408.
2005
-
Association of height with outcomes in patients with acute myocardial infarction receiving reperfusion therapy..
95:1371-1375.
2005
-
Diabetes-related knowledge, atherosclerotic risk factor control, and outcomes in acute coronary syndromes..
95:1290-1294.
2005
-
Meta-analysis of survival and relief of angina pectoris after transmyocardial revascularization..
95:1243-1245.
2005
-
Outcomes following elective percutaneous coronary intervention without on-site surgical backup in a community hospital..
95:1091-1093.
2005
-
Safety and effectiveness of transdermal nicotine patch in smokers admitted with acute coronary syndromes..
95:976-978.
2005
-
The N-terminal Pro-BNP investigation of dyspnea in the emergency department (PRIDE) study..
95:948-954.
2005
-
Aspirin resistance and a single gene..
95:805-808.
2005
-
Comparison of ST-segment resolution with combined fibrinolytic and glycoprotein IIb/IIIa inhibitor therapy versus fibrinolytic alone (data from four clinical trials)..
95:611-614.
2005
-
Impact of nonfatal myocardial infarction on outcomes in patients with advanced heart failure and the effect of bucindolol therapy..
95:558-564.
2005
-
Prognostic usefulness of white blood cell count and temperature in acute myocardial infarction (from the CARDINAL Trial)..
95:614-618.
2005
-
Angiographic and clinical outcomes associated with direct versus conventional stenting among patients treated with fibrinolytic therapy for ST-elevation acute myocardial infarction..
95:383-386.
2005
-
Lipid management in patients with unstable angina pectoris and non-ST-segment elevation acute myocardial infarction (from CRUSADE)..
95:483-485.
2005
-
Design of the SHock Inhibition Evaluation with Azimilide (SHIELD) study: a novel method to assess antiarrhythmic drug effect in patients with an implantable cardioverter-defibrillator..
95:274-276.
2005
-
Incremental prognostic power of single-photon emission computed tomographic myocardial perfusion imaging in patients with known or suspected coronary artery disease..
95:182-188.
2005
-
Simplified peak power reserve in patients with an implantable cardioverter-defibrillator and advanced heart failure..
95:286-288.
2005
-
Clinical characteristics of hypotension in patients with acute aortic dissection.
95:48-52.
2005
-
Evaluation of the Medtronic (Driver) cobalt-chromium alloy coronary stent system..
95:8-12.
2005
-
Impact of stenting and abciximab in patients with diabetes mellitus undergoing primary angioplasty in acute myocardial infarction (the CADILLAC trial)..
95:1-7.
2005
-
Relation of impaired Thrombolysis In Myocardial Infarction myocardial perfusion grades to residual thrombus following the restoration of epicardial patency in ST-elevation myocardial infarction..
95:224-227.
2005
-
Assessment of derived 12-lead electrocardiograms using general and patient-specific reconstruction strategies at rest and during transient myocardial ischemia..
94:1529-1533.
2004
-
Comparison of eight- versus 16-slice multidetector-row computed tomography for visibility and image quality of coronary segments.
94:1539-1543.
2004
-
Association between exercise capacity and left ventricular geometry in overweight patients with mild systemic hypertension..
94:1322-1325.
2004
-
Influence of admission and discharge aspirin use on survival after primary coronary angioplasty for acute myocardial infarction..
94:1029-1033.
2004
-
Predictors of and outcomes of early thrombosis following balloon angioplasty versus primary stenting in acute myocardial infarction and usefulness of abciximab (the CADILLAC trial)..
94:983-988.
2004
-
Cardiac troponin T elevation after coronary artery bypass grafting is associated with increased one-year mortality..
94:879-881.
2004
-
Optimal duration of eptifibatide infusion in percutaneous coronary intervention (an ESPRIT substudy)..
94:926-929.
2004
-
Association of race with complications and prognosis following acute coronary syndromes..
94:792-794.
2004
-
Effectiveness and tolerability of ezetimibe add-on therapy to a bile acid resin-based regimen for hypercholesterolemia..
94:795-797.
2004
-
Is rhythm control superior to rate control in patients with atrial fibrillation and congestive heart failure?.
94:797-800.
2004
-
Magnitude and impact of treatment delays on weeknights and weekends in patients undergoing primary angioplasty for acute myocardial infarction (the cadillac trial)..
94:637-A9.
2004
-
Usefulness of spironolactone in a specialized heart failure clinic..
94:443-447.
2004
-
Comparison of aortic dissection in patients with and without Marfan's syndrome (results from the International Registry of Aortic Dissection)..
94:400-402.
2004
-
Comparison of low risk and higher risk profiles in middle age to frequency and quantity of coronary artery calcium years later..
94:367-369.
2004
-
Efficacy and safety of two unfractionated heparin dosing strategies with tenecteplase in acute myocardial infarction (results from Assessment of the Safety and Efficacy of a New Thrombolytic Regimens 2 and 3)..
94:279-283.
2004
-
A further subgroup analysis of the effects of the DASH diet and three dietary sodium levels on blood pressure: results of the DASH-Sodium Trial..
94:222-227.
2004
-
In-hospital mortality associated with the use of intra-aortic balloon counterpulsation..
94:181-185.
2004
-
Relation of an elevated white blood cell count after percutaneous coronary intervention to long-term mortality..
94:190-192.
2004
-
Double jeopardy of renal insufficiency and anemia in patients undergoing percutaneous coronary interventions..
94:30-34.
2004
-
One-year outcome of patients after acute coronary syndromes (from the Canadian Acute Coronary Syndromes Registry)..
94:25-29.
2004
-
Efficacy and safety of ezetimibe co-administered with simvastatin compared with atorvastatin in adults with hypercholesterolemia..
93:1487-1494.
2004
-
Combined assessment of thrombolysis in myocardial infarction flow grade, myocardial perfusion grade, and ST-segment resolution to evaluate epicardial and myocardial reperfusion..
93:1362-A6.
2004
-
Effect of multielement intravascular ultrasound on the anticoagulant potency of enoxaparin..
93:1453-A12.
2004
-
Usefulness of an elevated troponin-I in predicting clinical events in patients admitted with acute heart failure and acute coronary syndrome (from the RITZ-4 trial)..
93:1436-A10.
2004
-
Effects of daily stress on autonomic cardiac control in patients with coronary artery disease..
93:1292-1294.
2004
-
Usefulness of myocardial viability or ischemia in predicting long-term survival for patients with severe left ventricular dysfunction undergoing revascularization..
93:1275-1279.
2004
-
Predischarge initiation of carvedilol in patients hospitalized for decompensated heart failure..
93:74B-76B.
2004
-
Effects of amino acid supplementation on left ventricular remodeling in patients with chronic heart failure with decreased systolic function and diabetes mellitus: rationale and design of a magnetic resonance imaging study..
93:44A-46A.
2004
-
Final results of the ReoPro readministration registry..
93:979-984.
2004
-
Tirofiban therapy for patients with acute coronary syndromes and prior coronary artery bypass grafting in the PRISM-PLUS trial..
93:843-847.
2004
-
Usefulness of percutaneous balloon mitral commissurotomy in preventing the development of atrial fibrillation in patients with mitral stenosis..
93:936-939.
2004
-
Effect of angiotensin-converting enzyme inhibitors, beta blockers, statins, and aspirin on C-reactive protein levels in outpatients with heart failure..
93:783-785.
2004
-
Comparison of visibility and diagnostic capability of noninvasive coronary angiography by eight-slice multidetector-row computed tomography versus conventional coronary angiography.
93:537-542.
2004
-
Feasibility of endovascular cooling as an adjunct to primary percutaneous coronary intervention (results of the LOWTEMP pilot study)..
93:636-639.
2004
-
Heart rate variability in atrial fibrillation related to left atrial size.
93:705-709.
2004
-
Prognostic usefulness of left ventricular thrombus by echocardiography in dilated cardiomyopathy in predicting stroke, transient ischemic attack, and death..
93:500-503.
2004
-
Risk factors for intracranial hemorrhage and nonhemorrhagic stroke after fibrinolytic therapy (from the GUSTO-i trial)..
93:458-461.
2004
-
Rate control in patients with chronic atrial fibrillation..
93:329-332.
2004
-
Relation between late patency of the infarct-related artery, left ventricular function, and clinical outcomes after primary percutaneous intervention for acute myocardial infarction (CADILLAC trial)..
93:349-353.
2004
-
Treating to New Targets (TNT) Study: does lowering low-density lipoprotein cholesterol levels below currently recommended guidelines yield incremental clinical benefit?.
93:154-158.
2004
-
Effectiveness of percutaneous coronary intervention in cardiac allograft vasculopathy..
93:90-92.
2004
-
Depression as a risk factor for mortality after acute myocardial infarction..
92:1277-1281.
2003
-
Influence of depression and effect of treatment with sertraline on quality of life after hospitalization for acute coronary syndrome..
92:1271-1276.
2003
-
Usefulness of frequent arrhythmias after epicardial recanalization in anterior wall acute myocardial infarction as a marker of cellular injury leading to poor recovery of left ventricular function..
92:1143-1149.
2003
-
American Journal of Cardiology: Introduction.
92.
2003
-
Current perceptions of cardiovascular gene therapy..
92:18N-23N.
2003
-
Evolving revascularization approaches for myocardial ischemia..
92:9N-17N.
2003
-
Predicting the future of human gene therapy for cardiovascular diseases: what will the management of coronary artery disease be like in 2005 and 2010?.
92:32N-35N.
2003
-
Comparison of outcomes of patients with acute coronary syndromes with and without atrial fibrillation..
92:1031-1036.
2003
-
Outcomes following bail-out abciximab administration during primary intervention in acute myocardial infarction (The CADILLAC Trial)..
92:1091-1094.
2003
-
Outcomes of bail-out stenting for suboptimal balloon angioplasty during primary intervention in acute myocardial infarction (The CADILLAC trial)..
92:1095-1098.
2003
-
Efficacy and safety of sustained-release propafenone (propafenone SR) for patients with atrial fibrillation..
92:941-946.
2003
-
Feasibility and implications of an early discharge strategy after percutaneous intervention with abciximab in acute myocardial infarction (the CADILLAC Trial)..
92:779-784.
2003
-
Complications arising after implantation of DDD pacemakers: the MOST experience..
92:740-741.
2003
-
Meta-analysis of survival with platelet glycoprotein IIb/IIIa antagonists for percutaneous coronary interventions..
92:651-655.
2003
-
Reduction of myocardial ischemic injury following coronary intervention (the MC-1 to Eliminate Necrosis and Damage trial)..
92:660-664.
2003
-
Effect of smoking and sedentary behavior on the association between depressive symptoms and mortality from coronary heart disease..
92:529-532.
2003
-
Usefulness of anemia as a predictor of death and rehospitalization in patients with decompensated heart failure..
92:625-628.
2003
-
Frequency of stent thrombosis after acute coronary syndromes (from the SYMPHONY and 2nd SYMPHONY trials)..
92:330-333.
2003
-
Comparison of 30-day outcome, resource use, and coronary artery disease severity in patients with suspected coronary artery disease with and without diabetes mellitus assigned to chest pain units..
91:1228-1230.
2003
-
Pharmacologic therapy for patients with chronic heart failure and reduced systolic function: review of trials and practical considerations..
91:18F-40F.
2003
-
Durability of platelet inhibition by clopidogrel..
91:1123-1125.
2003
-
Factors associated with ventricular inducibility in the MADIT-II study population..
91:1002-A7.
2003
-
Prognostic value of isolated troponin elevation across the spectrum of chest pain syndromes..
91:936-940.
2003
-
Relation of frequency and severity of mitral regurgitation to survival among patients with left ventricular systolic dysfunction and heart failure..
91:538-543.
2003
-
Comparison of one-year outcomes...ESPRIT. Enhanced Suppression of the Platelet IIb/IIIa Receptor With Integrilin Therapy..
91:514-515.
2003
-
Interactions between age, outcome of acute coronary syndromes, and tirofiban therapy..
91:457-461.
2003
-
Reply.
91:515-515.
2003
-
Time-dependent predictors of primary cardiac arrest in patients with acute myocardial infarction..
91:280-286.
2003
-
Clinical outcomes in patients on beta-blocker therapy admitted with worsening chronic heart failure..
91:169-174.
2003
-
Efficacy and safety of minimal dose (.
91:1-5.
2003
-
Efficacy and safety of minimal dose (< or =1,000 units) unfractionated heparin with abciximab in percutaneous coronary intervention..
91:1-5.
2003
-
Outpatient prescribing of antiarrhythmic drugs from 1995 to 2000..
91:91-94.
2003
-
Treatment effects of eptifibatide in planned coronary stent implantation in patients with chronic kidney disease (ESPRIT Trial)..
91:17-21.
2003
-
Comparison of outcomes of patients with myocardial infarction when living alone versus those not living alone..
90:1374-1377.
2002
-
Effects of renal insufficiency on early invasive management in patients with acute coronary syndromes (The TACTICS-TIMI 18 Trial)..
90:1246-1249.
2002
-
Effect of abciximab on angiographic complications during percutaneous coronary stenting in the Evaluation of Platelet IIb/IIIa Inhibition in Stenting Trial (EPISTENT)..
90:916-921.
2002
-
Abciximab survival advantage following percutaneous coronary intervention is predicted by clinical risk profile..
90:628-630.
2002
-
Comparison of one-year outcomes following coronary artery stenting in diabetic versus nondiabetic patients (from the Enhanced Suppression of the Platelet IIb/IIIa Receptor With Integrilin Therapy [ESPRIT] Trial)..
90:585-590.
2002
-
Seeking the optimal aspirin dose in acute coronary syndromes..
90:622-625.
2002
-
Effect of loading with clopidogrel at the time of coronary stenting on platelet aggregation and glycoprotein IIb/IIIa expression and platelet-leukocyte aggregate formation..
90:312-315.
2002
-
Relation of platelet activation and myocardial ischemia biomarkers dependent on type of chest pain (abrupt onset versus intermittent) in patients with angina pectoris or non-Q-wave acute myocardial infarction..
90:310-312.
2002
-
Thresholds for the electrocardiographic change range of biochemical markers of acute myocardial infarction (GUSTO-IIa data)..
90:233-237.
2002
-
Comparison of cardiac marker concentrations in healthy blood donors and hospital patients without acute coronary syndrome..
90:177-178.
2002
-
Comparison of coronary artery bypass grafting versus medical therapy on long-term outcome in patients with ischemic cardiomyopathy (a 25-year experience from the Duke Cardiovascular Disease Databank)..
90:101-107.
2002
-
Elucidation of the molecular mechanism of action of selective estrogen receptor modulators..
90:35F-43F.
2002
-
Impact of body mass index on outcome after percutaneous coronary intervention (the obesity paradox)..
90:42-45.
2002
-
Patient-reported frequency of taking aspirin in a population with coronary artery disease..
89:1042-1046.
2002
-
Comparison of impedance cardiography with invasive hemodynamic measurements in patients with heart failure secondary to ischemic or nonischemic cardiomyopathy..
89:993-995.
2002
-
The coxib story: some lessons and more questions..
89:971-972.
2002
-
Changes in hemodynamics and left ventricular structure after menopause..
89:830-833.
2002
-
Extent of, and factors associated with, delay to hospital presentation in patients with acute coronary disease (the GRACE registry)..
89:791-796.
2002
-
Long-term safety and efficacy of a once-daily niacin/lovastatin formulation for patients with dyslipidemia..
89:672-678.
2002
-
Underuse of aspirin in a referral population with documented coronary artery disease..
89:653-661.
2002
-
Iatrogenic aortic dissection..
89:623-626.
2002
-
Usefulness of psychosocial treatment of mental stress-induced myocardial ischemia in men..
89:164-168.
2002
-
In-hospital costs of coronary stent implantation with and without eptifibatide (the ESPRIT Trial). Enhanced Suppression of the Platelet IIb/IIIa Receptor with Integrilin..
89:61-64.
2002
-
Comparison of benefits and complications of hirudin versus heparin for patients with acute coronary syndromes undergoing early percutaneous coronary intervention..
88:1403-A6.
2001
-
Testing an intervention to increase cardiac rehabilitation enrollment after coronary artery bypass grafting..
88:1415-A6.
2001
-
Prospective comparison of hemorrhagic complications after treatment with enoxaparin versus unfractionated heparin for unstable angina pectoris or non-ST-segment elevation acute myocardial infarction..
88:1230-1234.
2001
-
Safety of the weight-adjusted dosing regimen of tenecteplase in the ASSENT-Trial..
88:1240-1245.
2001
-
Clinical pharmacology of higher dose eptifibatide in percutaneous coronary intervention (the PRIDE study)..
88:1097-1102.
2001
-
The relevance of tissue angiotensin-converting enzyme: manifestations in mechanistic and endpoint data..
88:1L-20L.
2001
-
Comparison of results of percutaneous balloon mitral commissurotomy in patients aged > or = 65 years with those in patients aged < 65 years..
88:994-1000.
2001
-
Effect of eptifibatide on angiographic complications during percutaneous coronary intervention in the IMPACT--(Integrilin to Minimize Platelet Aggregation and Coronary Thrombosis) II Trial..
88:969-973.
2001
-
Prognostic usefulness of the six-minute walk in patients with advanced congestive heart failure secondary to ischemic or nonischemic cardiomyopathy..
88:987-993.
2001
-
Comparison of primary coronary angioplasty versus thrombolysis in patients with ST-segment elevation acute myocardial infarction and grade II and grade III myocardial ischemia on the enrollment electrocardiogram..
88:842-847.
2001
-
Refractory systemic hypertension following type B aortic dissection..
88:686-688.
2001
-
Does "Optimal" percutaneous transluminal coronary angioplasty (PTCA) provide equivalent outcomes in acute myocardial infarction (AMI) compared with stenting? Insights from the CADILLAC trial..
88:27G-27G.
2001
-
Does primary stenting benefit proximal LAD infarction? The CADILLAC trial..
88:64G-64G.
2001
-
Outcomes in elderly patients undergoing primary coronary intervention for AMI: Insights from the CADILLAC trial..
88:64G-65G.
2001
-
A risk score system for predicting adverse outcomes and magnitude of benefit with glycoprotein IIb/IIIa inhibitor therapy in patients with unstable angina pectoris..
88:488-492.
2001
-
Comparison of two aspirin doses on ischemic stroke in post-myocardial infarction patients in the warfarin (Coumadin) Aspirin Reinfarction Study (CARS)..
88:541-546.
2001
-
Association of noninvasive markers of coronary artery reperfusion to assess microvascular obstruction in patients with acute myocardial infarction treated with primary angioplasty..
88:342-346.
2001
-
Effect of gender on the outcomes of contemporary percutaneous coronary intervention..
88:359-364.
2001
-
Comparison of self-expanding and balloon-expandable stents for the reduction of restenosis..
88:253-259.
2001
-
Enhancing recovery in coronary heart disease (ENRICHD): baseline characteristics..
88:316-322.
2001
-
Initial experience with multivessel percutaneous coronary intervention during mechanical reperfusion for acute myocardial infarction..
88:170-A6.
2001
-
Atrial fibrillation and mortality among patients with acute coronary syndromes without ST-segment elevation: results from the PURSUIT trial..
88:A7-79.
2001
-
Effects of kaliuretic peptide on sodium and water excretion in persons with congestive heart failure..
88:23-29.
2001
-
Fractal correlation properties of heart rate dynamics and adverse events in patients with implantable cardioverter-defibrillators..
88:17-22.
2001
-
Gradient and spin echo(cardiographic) magnetic resonance imaging: prevalence of descriptive errors in published articles..
88:A8-94.
2001
-
Effect of selective serotonin reuptake inhibitors on platelets in patients with coronary artery disease..
87:1398-1400.
2001
-
Effect of eptifibatide on coronary flow reserve following coronary stent implantation (an ESPRIT substudy). Enhanced Suppression of the Platelet IIb/IIIa Receptor with Integrilin Therapy..
87:1293-1295.
2001
-
Association between selective serotonin-reuptake inhibitor therapy and heart valve regurgitation..
87:989-93: A4.
2001
-
Significance of recurrent pain in acute type B aortic dissection..
87:930-933.
2001
-
Electrophysiologic and clinical effects of angiotensin-converting enzyme inhibitors in patients with prior myocardial infarction, nonsustained ventricular tachycardia, and depressed left ventricular function. MUSTT Investigators. Multicenter UnSustained Tachycardia Trial..
87:716-720.
2001
-
Relation of soluble and platelet P-selectin to early outcome in patients with acute myocardial infarction after thrombolytic therapy..
87:774-A7.
2001
-
Prognostic importance of concomitant heparin with eptifibatide in acute coronary syndromes. PURSUIT Investigators. Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy..
87:532-536.
2001
-
Effectiveness and safety of abciximab after failed thrombolytic therapy..
87:439-A4.
2001
-
Effect of diabetes mellitus and insulin use on survival after acute myocardial infarction in the elderly (the Cooperative Cardiovascular Project)..
87:272-277.
2001
-
Effect of increased body mass index on accuracy of two-dimensional echocardiography for measurement of left ventricular volume, ejection fraction, and mass..
87:371-A10.
2001
-
Usefulness of diabetic retinopathy as a marker of risk for thallium myocardial perfusion defects in non-insulin-dependent diabetes mellitus..
87:456-9, A6.
2001
-
Age and the utilization of cardiac catheterization following uncomplicated first acute myocardial infarction treated with thrombolytic therapy (The Second National Registry of Myocardial Infarction [NRMI-2]).
88:107-111.
2001
-
Introduction: evidence to practice in acute coronary syndromes..
86:1M-3M.
2000
-
Strategies of patient care in acute coronary syndromes: rationale for the Global Registry of Acute Coronary Events (GRACE) registry..
86:4M-9M.
2000
-
Comparison of medicine alone, coronary angioplasty, and left internal mammary artery-coronary artery bypass for one-vessel proximal left anterior descending coronary artery disease..
86:1322-1326.
2000
-
Robust benefit of glycoprotein IIb/IIIa inhibition with eptifibatide in patients undergoing stent percutaneous coronary intervention with positive cardiac markers at baseline..
86:13I-14I.
2000
-
Clinical and electrocardiographic variables associated with increased risk of ventricular septal defect in acute anterior myocardial infarction..
86:830-834.
2000
-
Clinical characteristics and long-term outcomes of patients with heart failure and preserved systolic function..
86:863-867.
2000
-
Costs of revascularization over eight years in the randomized and eligible patients in the Emory Angioplasty versus Surgery Trial (EAST)..
86:747-752.
2000
-
Effects of tirofiban plus heparin versus heparin alone on troponin I levels in patients with acute coronary syndromes..
86:713-717.
2000
-
Moderators of the effect of social support on depressive symptoms in cardiac patients..
86:438-442.
2000
-
A prospective study of dominance and coronary heart disease in the Normative Aging Study..
86:145-149.
2000
-
Noninvasive strategies for the estimation of cardiac risk in stable chest pain patients. The Economics of Noninvasive Diagnosis (END) Study Group..
86:1-7.
2000
-
Use of resources, quality of life, and clinical outcomes in patients with and without new Q waves after thrombolytic therapy for acute myocardial infarction (from the GUSTO-I trial)..
86:24-29.
2000
-
Association of chronic congestive heart failure in humans with an intrinsic upregulation in skeletal muscle sarcoplasmic reticulum calcium ion adenosine triphosphatase activity..
85:1498-1500.
2000
-
Effects of a single intracoronary injection of basic fibroblast growth factor in stable angina pectoris..
85:1414-1419.
2000
-
Correlates and impact on outcomes of worsening renal function in patients > or =65 years of age with heart failure..
85:1110-1113.
2000
-
Multiple-dose efficacy and safety of an extended-release form of niacin in the management of hyperlipidemia..
85:1100-1105.
2000
-
The benefit of abciximab in percutaneous coronary revascularization is not device-specific..
85:1060-1064.
2000
-
The use of glycoprotein IIb/IIIa inhibitor therapy in acute ST-segment elevation myocardial infarction: current practice and future trends..
85:32C-38C.
2000
-
Comparison of cardiac troponin T versus creatine kinase-MB for risk stratification in a chest pain evaluation unit..
85:801-805.
2000
-
A comparison of ionic versus nonionic contrast medium during primary percutaneous transluminal coronary angioplasty for acute myocardial infarction (GUSTO IIb). Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes..
85:692-697.
2000
-
Applying the resource-based relative value scale to the Emory angioplasty versus surgery trial..
85:685-691.
2000
-
Quality of life after coronary revascularization in the United States and Canada..
85:548-553.
2000
-
Relation of temporal creatine kinase-MB release and outcome after thrombolytic therapy for acute myocardial infarction. TAMI Study Group..
85:543-547.
2000
-
Efficacy of abciximab readministration in coronary intervention..
85:435-440.
2000
-
Outcomes following interventions in small coronary arteries with the use of hand-crimped Palmaz-Schatz stents..
85:446-450.
2000
-
Timing of and risk factors for myocardial ischemic events after percutaneous coronary intervention (IMPACT-II). Integrilin to Minimize Platelet Aggregation and Coronary Thrombosis..
85:427-434.
2000
-
Lack of effect of increased inspired oxygen concentrations on maximal exercise capacity or ventilation in stable heart failure..
84:1412-1416.
1999
-
Prognostic value of thallium-201 single-photon emission computed tomography for patients with multivessel coronary artery disease after revascularization (the Emory Angioplasty versus Surgery Trial [EAST])..
84:1369-1374.
1999
-
Cost estimates for treatment of cardiac ischemia (from the Asymptomatic Cardiac Ischemia Pilot [ACIP] study)..
84:1311-1316.
1999
-
Real-time three-dimensional echocardiography for measurement of left ventricular volumes..
84:1434-1439.
1999
-
Risk stratification with a point-of-care cardiac troponin T test in acute myocardial infarction. GUSTOIII Investigators. Global Use of Strategies To Open Occluded Coronary Arteries..
84:1281-1286.
1999
-
Differences between men and women in the management of unstable angina pectoris (The GUARANTEE Registry). The GUARANTEE Investigators..
84:1145-1150.
1999
-
Effectiveness of early coronary angioplasty and abciximab for failed thrombolysis (reteplase or alteplase) during acute myocardial infarction (results from the GUSTO-III trial). Global Use of Strategies To Open occluded coronary arteries..
84:779-784.
1999
-
Abciximab reduces in-hospital events among patients undergoing percutaneous coronary intervention..
84:67P-67P.
1999
-
Abciximab reduces procedure time among patients undergoing percutaneous coronary intervention..
84:71P-71P.
1999
-
Direct myocardial revascularization and angiogenesis--how many patients might be eligible?.
84:598-A8.
1999
-
Dual hepatic metabolism of cerivastatin--clarifications..
84:497.
1999
-
Depression, coronary events, platelet inhibition, and serotonin reuptake inhibitors..
84:321-A8.
1999
-
Can cardiovascular clinical characteristics be identified and outcome models be developed from an in-patient claims database?.
84:166-169.
1999
-
Coronary artery restenosis after atherectomy is primarily due to negative remodeling..
84:141-146.
1999
-
Familial hypertrophic cardiomyopathy and atrial fibrillation caused by Arg663His beta-cardiac myosin heavy chain mutation..
83:13H-18H.
1999
-
Differences among the parenteral platelet glycoprotein IIb/IIIa inhibitors and implications for treatment..
83:7E-11E.
1999
-
Usefulness of soluble and surface-bound P-selectin in detecting heightened platelet activity in patients with congestive heart failure..
83:1345-1349.
1999
-
Echocardiographic characteristics of successful deployment of the Das AngelWings atrial septal defect closure device: initial multicenter experience in the United States..
83:1236-1241.
1999
-
Prior aspirin use predicts worse outcomes in patients with non-ST-elevation acute coronary syndromes. PURSUIT Investigators. Platelet IIb/IIIa in Unstable angina: Receptor Suppression Using Integrilin Therapy..
83:1147-1151.
1999
-
Cardiac troponin T and I, echocardiographic [correction of electrocardiographic] wall motion analyses, and ejection fractions in athletes participating in the Hawaii Ironman Triathlon..
83:1085-1089.
1999
-
Comparison of slow oscillating versus fast balloon inflation strategies for coronary angioplasty..
83:675-680.
1999
-
Support for the open-artery hypothesis in survivors of acute myocardial infarction: analysis of 11,228 patients treated with thrombolytic therapy..
83:482-487.
1999
-
Economics, health-related quality of life, and cost-effectiveness methods for the TACTICS (Treat Angina With Aggrastat [tirofiban]] and Determine Cost of Therapy with Invasive or Conservative Strategy)-TIMI 18 trial..
83:317-322.
1999
-
Consensus recommendations for the management of chronic heart failure. On behalf of the membership of the advisory council to improve outcomes nationwide in heart failure..
83:1A-38A.
1999
-
Correlation of angiographic findings and right (V1 to V3) versus left (V4 to V6) precordial ST-segment depression in inferior wall acute myocardial infarction..
83:143-148.
1999
-
Predictors and significance of atrial rhythm before and six months after percutaneous balloon mitral commissurotomy..
83:125-A9.
1999
-
Thrombosis and the role of the platelet.
83:3E-6E.
1999
-
A new extended-release niacin (Niaspan): efficacy, tolerability, and safety in hypercholesterolemic patients..
82:29U-34U.
1998
-
Advances in dyslipidemia: Discussion session II.
82:85U-86U.
1998
-
Effect of niacin on atherosclerotic cardiovascular disease..
82:18U-23U.
1998
-
Efficacy and safety of an extended-release niacin (Niaspan): a long-term study..
82:74U-81U.
1998
-
Introduction.
82.
1998
-
Treatment of hyperlipidemia with combined niacin-statin regimens..
82:82U-84U.
1998
-
Relation between the number of image planes and the accuracy of three-dimensional echocardiography for measuring left ventricular volumes and ejection fraction..
82:1431-A9.
1998
-
What does the left atrial v wave signify during balloon commissurotomy of mitral stenosis?.
82:1388-1393.
1998
-
Acute hemodynamic changes during carotid artery stenting..
82:1077-1081.
1998
-
Reduction in the need for unplanned stenting with the use of platelet glycoprotein IIb/IIIa blockade in percutaneous coronary intervention..
82:1105-A6.
1998
-
A perspective on the regulation of the evaluation of new antithrombotic drugs..
82:25P-35P.
1998
-
Mechanisms of atrial fibrillation and action of drugs used in its management..
82:43N-49N.
1998
-
Selecting an antiarrhythmic agent for atrial fibrillation should be a patient-specific, data-driven decision..
82:72N-81N.
1998
-
Abciximab benefit in coronary intervention has no gender bias: Results of EPIC, EPILOG and CAPTURE trials..
82:95S-95S.
1998
-
Effect of amlodipine on mode of death among patients with advanced heart failure in the PRAISE trial. Prospective Randomized Amlodipine Survival Evaluation..
82:881-887.
1998
-
Effectiveness of once-nightly dosing of extended-release niacin alone and in combination for hypercholesterolemia..
82:737-743.
1998
-
Low-molecular-weight heparins in non-ST-segment elevation ischemia: the ESSENCE trial. Efficacy and Safety of Subcutaneous Enoxaparin versus intravenous unfractionated heparin, in non-Q-wave Coronary Events..
82:19L-24L.
1998
-
Diagnosing coronary arterial stent thrombosis and arterial closure..
82:666-A6.
1998
-
Local administration of L-703,081 using a composite polymeric stent reduces platelet deposition in canine coronary arteries..
82:673-A8.
1998
-
Robert McKinnon Califf, MD: a conversation with the editor. Interview by William Clifford Roberts..
82:639-658.
1998
-
Causes and consequences of discontinuation of the implantable cardioverter-defibrillator therapy in non-terminally ill patients..
81:1203-1205.
1998
-
Higher T-wave amplitude associated with better prognosis in patients receiving thrombolytic therapy for acute myocardial infarction (a GUSTO-I substudy). Global Utilization of Streptokinase and Tissue plasminogen Activator for Occluded Coronary Arteries..
81:1078-1084.
1998
-
A randomized trial of vascular hemostasis techniques to reduce femoral vascular complications after coronary intervention..
81:970-976.
1998
-
Soluble vascular cell adhesion molecule-1 and E-selectin in patients with acute myocardial infarction treated with thrombolytic agents..
81:772-775.
1998
-
Aggressive lipid lowering in postcoronary angioplasty patients with elevated cholesterol (the Lovastatin Restenosis Trial)..
81:632-636.
1998
-
Benefit of early sustained reperfusion in patients with prior myocardial infarction (the GUSTO-I trial). Global Utilization of Streptokinase and TPA for occluded arteries..
81:282-287.
1998
-
Effects of prior aspirin and anti-ischemic therapy on outcome of patients with unstable angina.
81:678-681.
1998
-
Platelet glycoprotein IIb/IIIa receptor blockade with abciximab reduces ischemic complications in patients undergoing directional coronary atherectomy.
82:7-12.
1998
-
Vascular access site complications after percutaneous coronary intervention with abciximab in the Evaluation of c7E3 for the Prevention of Ischemic Complications (EPIC) trial..
81:36-40.
1998
-
Cost effectiveness of inpatient initiation of antiarrhythmic therapy for supraventricular tachycardias..
80:1551-1557.
1997
-
Excimer laser coronary angioplasty: the New Approaches to Coronary Intervention (NACI) experience..
80:99K-105K.
1997
-
Predictors of acute and long-term outcome with transluminal extraction atherectomy: the New Approaches to Coronary Intervention (NACI) registry..
80:68K-77K.
1997
-
Evaluation and clinical application of a direct low-density lipoprotein cholesterol assay in normolipidemic and hyperlipidemic adults..
80:1295-1299.
1997
-
Left ventricular hypertrophy in athletes..
80:1384-1388.
1997
-
Treatment of hyperlipidemia by specialists versus generalists as secondary prevention of coronary artery disease..
80:1345-1347.
1997
-
Future horizons in cardiovascular molecular therapeutics..
80:33I-39I.
1997
-
Economics of treating heart failure..
80:33H-38H.
1997
-
Effect of platelet glycoprotein IIb/IIIa receptor inhibition on distal embolization during percutaneous revascularization of aortocoronary saphenous vein grafts. EPIC Investigators. Evaluation of IIb/IIIa platelet receptor antagonist 7E3 in Preventing Ischemic Complications..
80:985-988.
1997
-
Ability of heart rate variability to predict prognosis in patients with advanced congestive heart failure..
80:808-811.
1997
-
Roundtable panel discussion: The role of glycoprotein IIb-IIIa receptor inhibitors in acute ischemic coronary syndromes.
80.
1997
-
Who are the MADIT patients? Multicenter Automatic Defibrillator Implantation Trial..
80:42F-46F.
1997
-
Impact of eptifibatide on early ischemic events in acute ischemic coronary syndromes: a review of the IMPACT II trial. Integrilin to Minimize Platelet Aggregation and Coronary Thrombosis..
80:21B-28B.
1997
-
Roundtable panel discussion: the role of glycoprotein IIb-IIIa receptor inhibitors in acute ischemic coronary syndromes..
80:44B-48B.
1997
-
Electrocardiographic differentiation of the ST-segment depression of acute myocardial injury due to the left circumflex artery occlusion from that of myocardial ischemia of nonocclusive etiologies..
80:512-513.
1997
-
Blood pressure responses to mental stress in emotionally defensive patients with stable coronary artery disease..
80:343-346.
1997
-
Role of right ventricular and pulmonary functional abnormalities in limiting exercise capacity in adults with congenital heart disease..
80:315-322.
1997
-
Effect of inadequate cardiac output reserve on exercise tolerance in patients with moderate mitral stenosis..
80:236-240.
1997
-
Adenosine for myocardial protection in acute myocardial infarction..
79:44-48.
1997
-
Angioplasty or surgery for multivessel coronary artery disease: comparison of eligible registry and randomized patients in the EAST trial and influence of treatment selection on outcomes. Emory Angioplasty versus Surgery Trial Investigators..
79:1453-1459.
1997
-
Incidence and impact on outcome of streptokinase allergy in the GUSTO-I trial. Global Utilization of Streptokinase and t-PA in Occluded Coronary Arteries..
79:1232-1235.
1997
-
Reasons for underuse of angiotensin-converting enzyme inhibitors in patients with heart failure and left ventricular dysfunction..
79:1118-1120.
1997
-
Association of systolic blood pressure at time of myocardial ischemia with angina pectoris during exercise testing..
79:954-956.
1997
-
Use of evidence-based medical therapy in patients undergoing percutaneous coronary revascularization in the United States, Europe, and Canada. Coronary Angioplasty Versus Excisional Atherectomy Trial (CAVEAT-I) and Canadian Coronary Atherectomy Trial (CCAT) investigators..
79:867-872.
1997
-
Usefulness of serial radionuclide angiography in predicting cardiac death after coronary artery bypass grafting and comparison with clinical and cardiac catheterization data..
79:851-855.
1997
-
Impact of diabetes mellitus on percutaneous revascularization (CAVEAT-I). CAVEAT-I Investigators. Coronary Angioplasty Versus Excisional Atherectomy Trial..
79:748-755.
1997
-
Economic implications of the prophylactic use of intraaortic balloon counterpulsation in the setting of acute myocardial infarction. The Randomized IABP Study Group. Intraaortic Balloon Pump..
79:590-594.
1997
-
Effects of thrombolytic regimen, early catheterization, and predischarge angiographic variables on six-week left ventricular function. The TAMI Investigators. Thrombolysis and Angioplasty in Acute Myocardial Infarction..
79:539-544.
1997
-
Predicting adverse outcome with exercise SPECT technetium-99m sestamibi imaging in patients with suspected or known coronary artery disease..
79:270-274.
1997
-
Standard versus low-dose weight-adjusted heparin in patients treated with the platelet glycoprotein IIb/IIIa receptor antibody fragment abciximab (c7E3 Fab) during percutaneous coronary revascularization. PROLOG Investigators..
79:286-291.
1997
-
Introduction.
80.
1997
-
New approaches to cardiovascular therapy: Panel discussion.
80.
1997
-
How much do we gain by reducing time to reperfusion therapy?.
78:8-15.
1996
-
A metaanalysis of predischarge risk stratification after acute myocardial infarction with stress electrocardiographic, myocardial perfusion, and ventricular function imaging..
78:1327-1337.
1996
-
Cardiac vagal control and dynamic responses to psychological stress among patients with coronary artery disease..
78:1424-1427.
1996
-
Evaluation of the effect of transthoracic cardioversion from ventricular tachycardia to sinus rhythm on left atrial mechanical function..
78:1436-1439.
1996
-
Thrombolytic therapy for patients with prior percutaneous transluminal coronary angioplasty and subsequent acute myocardial infarction. GUSTO-I Investigators. Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries..
78:1338-1344.
1996
-
Is there a bias against performing coronary revascularization in women?.
78:1154-1160.
1996
-
A comparison of debulking versus dilatation of bifurcation coronary arterial narrowings (from the CAVEAT I Trial). Coronary Angioplasty Versus Excisional Atherectomy Trial-I..
78:1039-1041.
1996
-
Evaluation of left atrial appendage anatomy and function in recent-onset atrial fibrillation by transesophageal echocardiography..
78:774-778.
1996
-
Collagen subtypes III and IV expression in human vein graft atherosclerosis..
78:691-694.
1996
-
Depression and long-term mortality risk in patients with coronary artery disease..
78:613-617.
1996
-
Why cardiologists should be interested in estrogen..
78:559-561.
1996
-
Prediction of the infarct-related artery in acute myocardial infarction by a scoring system using summary ST-segment and T-wave changes..
78:389-395.
1996
-
Glycoprotein IIb/IIIa receptor inhibitors: putting the EPIC, IMPACT II, RESTORE, and EPILOG trials into perspective..
78:35-40.
1996
-
Compression of digital coronary angiograms does not affect visual or quantitative assessment of coronary artery stenosis severity..
78:131-135.
1996
-
Ethnic differences in forearm vasodilator capacity..
78:208-211.
1996
-
Relation of lumen size to restenosis after percutaneous transluminal coronary balloon angioplasty. Lovastatin Restenosis Trial Group..
78:221-224.
1996
-
Metaanalysis of five reported studies on the relation of early coronary patency grades with mortality and outcomes after acute myocardial infarction..
78:1-8.
1996
-
Use of calcium channel antagonists in myocardial revascularization procedures..
77:26D-31D.
1996
-
Effects of platelet glycoprotein IIb/IIIa receptor blockade by a chimeric monoclonal antibody (abciximab) on acute and six-month outcomes after percutaneous transluminal coronary angioplasty for acute myocardial infarction. EPIC investigators..
77:1045-1051.
1996
-
A randomized factorial trial of reperfusion strategies and aspirin dosing in acute myocardial infarction. The DUCCS-II Investigators..
77:791-797.
1996
-
Overview of randomized trials of intravenous heparin in patients with acute myocardial infarction treated with thrombolytic therapy..
77:551-556.
1996
-
Negative predictive value of the Duke criteria for infective endocarditis..
77:403-407.
1996
-
Glycoprotein IIb/IIIa receptor inhibitors: Putting the EPIC, IMPACT II, RESTORE, and EPILOG trials into perspective.
78:35-40.
1996
-
Prognostic value of plasma fibrinogen concentration in patients with unstable angina and non-Q-wave myocardial infarction (TIMI IIIB trial).
78:142-147.
1996
-
Immediate and reversible platelet inhibition after intravenous administration of a peptide glycoprotein IIb/IIIa inhibitor during percutaneous coronary intervention..
76:1222-1227.
1995
-
Implications for cost-effectiveness.
76:1182.
1995
-
The way of the future redux..
76:1177-1182.
1995
-
Frequency, significance, and cost of recurrent ischemia after thrombolytic therapy for acute myocardial infarction. TAMI Study Group..
76:1007-1013.
1995
-
Left ventricular performance improves late after aortic valve replacement in patients with aortic stenosis and reduced ejection fraction..
76:612-615.
1995
-
Multiplane transesophageal echocardiographic assessment of left atrial appendage anatomy and function..
76:528-530.
1995
-
Relative importance of electrode placement over number of channels in transient myocardial ischemia detection by Holter monitoring..
76:350-354.
1995
-
Importance of baseline functional and socioeconomic factors for participation in cardiac rehabilitation..
76:36-39.
1995
-
Distinguishing between early and late responders to symptoms of acute myocardial infarction..
75:1019-1022.
1995
-
Usefulness of ischemic response to mental stress in predicting silent myocardial ischemia during ambulatory monitoring..
75:1007-1011.
1995
-
Significance of a coronary artery with thrombolysis in myocardial infarction grade 2 flow "patency" (outcome in the thrombolysis and angioplasty in myocardial infarction trials). Thrombolysis and Angioplasty in Myocardial Infarction Study Group..
75:871-876.
1995
-
Coronary anatomic and procedural characteristics of patients randomized to coronary angioplasty in the Bypass Angioplasty Revascularization Investigation (BARI)..
75:27C-33C.
1995
-
Emory Angioplasty Versus Surgery Trial (EAST): design, recruitment, and baseline description of patients..
75:42C-59C.
1995
-
Initial functional and economic status of patients with multivessel coronary artery disease randomized in the Bypass Angioplasty Revascularization Investigation (BARI)..
75:34C-41C.
1995
-
Effect of platelet glycoprotein IIb/IIIa integrin blockade on activated clotting time during percutaneous transluminal coronary angioplasty or directional atherectomy (the EPIC trial). Evaluation of c7E3 Fab in the Prevention of Ischemic Complications trial..
75:559-562.
1995
-
Temporal dependence of the return of atrial mechanical function on the mode of cardioversion of atrial fibrillation to sinus rhythm..
75:624-626.
1995
-
Predictors of outcome of tricuspid valve replacement in carcinoid heart disease..
75:485-488.
1995
-
Left ventricular mass and diastolic filling patterns in quadriplegia and implications for effects of normal aging on the heart..
75:201-203.
1995
-
Transesophageal echocardiographic assessment of reversal of systolic pulmonary venous flow in mitral stenosis..
75:58-60.
1995
-
A pooled analysis of coronary arterial patency and left ventricular function after intravenous thrombolysis for acute myocardial infarction..
74:1220-1228.
1994
-
Effects of profound platelet inhibition with c7E3 before coronary angioplasty on complications of coronary bypass surgery. EPIC Investigators. Evaluation Prevention of Ischemic Complications..
74:1166-1170.
1994
-
Simultaneous ST-segment measurements using standard and monitoring-compatible torso limb lead placements at rest and during coronary occlusion..
74:997-1001.
1994
-
Quality-of-life assessment in patients with paroxysmal atrial fibrillation or paroxysmal supraventricular tachycardia..
74:826-829.
1994
-
Right ventricular infarction complicated by acute right-to-left shunting..
74:824-826.
1994
-
Value of transthoracic echocardiography in predicting embolic events in active infective endocarditis. Duke Endocarditis Service..
74:799-801.
1994
-
Hostility in asymptomatic men with angiographically confirmed coronary artery disease..
74:439-442.
1994
-
Importance of ST-segment depression as a determinant of ventricular premature complex frequency after thrombolysis for acute myocardial infarction. Tissue Plasminogen Activator: Toronto (TPAT) Study Group..
74:419-423.
1994
-
Frequency of transient reductions in left ventricular ejection fraction at rest in coronary artery disease..
74:137-143.
1994
-
Predictors of outcome of percutaneous excimer laser coronary angioplasty of saphenous vein bypass graft lesions. The Percutaneous Excimer Laser Coronary Angioplasty Registry..
74:144-148.
1994
-
Effects of heparin and cardiac catheterization on serum lipoprotein and triglyceride levels..
74:47-52.
1994
-
Successful use of education and cost-based feedback strategies to reduce physician utilization of low-osmolality contrast agents in the cardiac catheterization laboratory..
73:1219-1221.
1994
-
Comparison of continuous ST-segment recovery analysis with methods using static electrocardiograms for noninvasive patency assessment during acute myocardial infarction. Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) 7 Study Group..
73:1069-1074.
1994
-
Frequency of hypothyroidism in adults with serum total cholesterol levels > 200 mg/dl..
73:955-957.
1994
-
A meta-analysis of randomized trials of calcium antagonists to reduce restenosis after coronary angioplasty..
73:835-839.
1994
-
Does ambulatory monitoring contribute to exercise testing and myocardial perfusion scintigraphy in the prediction of the extent of coronary artery disease in stable angina?.
73:747-752.
1994
-
Double-blind coumadin research--an ethical dilemma..
73:725-726.
1994
-
Primary coronary angioplasty for acute myocardial infarction (the Primary Angioplasty Registry)..
73:627-634.
1994
-
An overview of risk assessment in coronary artery disease..
73:19B-25B.
1994
-
Programmed Outcome Research Teams (PORTs) and implications for clinical practice..
73:34B-38B.
1994
-
Intracranial hemorrhage risk and new thrombolytic therapies in acute myocardial infarction..
73:444-449.
1994
-
Reply.
73:725-726.
1994
-
Usefulness of dobutamine echocardiography for detecting restenosis after percutaneous transluminal coronary angioplasty..
72:1220-1225.
1993
-
Lack of usefulness of prolonged bleeding times in predicting hemorrhagic events in patients receiving the 7E3 glycoprotein IIb/IIIa platelet antibody. The TAMI Study Group..
72:1121-1125.
1993
-
Relation of cardiovascular responses to mental stress and cardiac vagal activity in coronary artery disease..
72:551-554.
1993
-
Impact of tissue plasminogen activator and heparin versus heparin alone on quantitative coronary angiographic findings in myocardial infarction. The Toronto Tissue Plasminogen Activator Trial Study Group..
72:379-383.
1993
-
Long-term outcome following successful reopening of abrupt closure after coronary angioplasty..
72:21-25.
1993
-
Comparison of results of percutaneous balloon valvuloplasty in patients with mild and moderate mitral stenosis to those with severe mitral stenosis. The North American Inoue Balloon Investigators..
71:1300-1303.
1993
-
Ratio of ST-segment and myoglobin slopes to estimate myocardial salvage during thrombolytic therapy for acute myocardial infarction..
71:1362-1365.
1993
-
Treatment of long coronary artery narrowings with long angioplasty balloon catheters..
71:1274-1277.
1993
-
Minimizing the risk of inappropriately administering thrombolytic therapy (Thrombolysis and Angioplasty in Myocardial Infarction [TAMI] study group)..
71:783-787.
1993
-
Relation between pulmonary artery pressure and mitral stenosis severity in patients undergoing balloon mitral commissurotomy..
71:874-878.
1993
-
In vivo validation of compensatory enlargement of atherosclerotic coronary arteries..
71:665-668.
1993
-
Continuously updated 12-lead ST-segment recovery analysis for myocardial infarct artery patency assessment and its correlation with multiple simultaneous early angiographic observations..
71:145-151.
1993
-
Unrecognized left main coronary artery disease in patients undergoing interventional procedures..
71:173-176.
1993
-
Clinical success, complications and restenosis rates with excimer laser coronary angioplasty. The Percutaneous Excimer Laser Coronary Angioplasty Registry..
70:1533-1539.
1992
-
Importance of early and complete reperfusion to achieve myocardial salvage after thrombolysis in acute myocardial infarction..
70:1391-1396.
1992
-
Autocrine and paracrine mechanisms in the pathophysiology of heart failure..
70:4C-11C.
1992
-
Performance status and outcome after coronary artery bypass grafting in persons aged 80 to 93 years..
70:567-571.
1992
-
Angiographic follow-up after internal mammary artery graft angioplasty..
70:401-403.
1992
-
Methodologic issues in clinical evaluation of stenosis severity in adults undergoing aortic or mitral balloon valvuloplasty. The NHLBI Balloon Valvuloplasty Registry..
69:1607-1616.
1992
-
Outcome after prolonged balloon inflations of greater than 20 minutes for initially unsuccessful percutaneous transluminal coronary angioplasty..
69:1417-1421.
1992
-
Calibration using angiographic catheters as scaling devices--importance of filming the catheters not filled with contrast medium..
69:1377-1378.
1992
-
Complex angioplasty: a surgeon's perspective..
69:22F-24F.
1992
-
Evaluation of a prolonged infusion of recombinant tissue-type plasminogen activator (Duteplase) in preventing reocclusion following successful thrombolysis in acute myocardial infarction..
69:1120-1127.
1992
-
Diagnosis and management (by subxiphoid pericardiotomy) of large pericardial effusions causing cardiac tamponade..
69:1075-1078.
1992
-
Fibrin modification by ionic and nonionic contrast media during cardiac catheterization..
69:821-823.
1992
-
Clinical risks of thrombolytic therapy..
69:12A-20A.
1992
-
Left ventricular filling and ventricular diastolic performance after percutaneous balloon mitral valvotomy..
69:108-112.
1992
-
Thrombin antagonists and antiplatelet agents.
69:A39-A51.
1992
-
Doppler echocardiographic findings in adults with severe symptomatic valvular aortic stenosis. Balloon Valvuloplasty Registry Echocardiographers..
68:1477-1484.
1991
-
Effect of digoxin on ST-segment changes detected by ambulatory electrocardiographic monitoring in healthy subjects..
68:1503-1506.
1991
-
Medical, ethical and legal issues regarding thrombolytic therapy in the Jehovah's Witness..
68:1525-1529.
1991
-
Intracoronary ultrasound evaluation of interventional technologies..
68:1305-1309.
1991
-
Doppler assessment of pulmonary artery flow patterns and ventricular function after the Fontan operation..
68:1211-1215.
1991
-
Pitfalls in the determination of absolute dimensions using angiographic catheters as calibration devices in quantitative angiography..
68:1176-1182.
1991
-
Comparison of cardiovascular and renal toxicity after cardiac catheterization using a nonionic versus ionic radiographic contrast agent..
68:1117-1119.
1991
-
Thrombolytic therapy in patients requiring cardiopulmonary resuscitation..
68:1015-1019.
1991
-
Effectiveness of percutaneous balloon mitral valvotomy during pregnancy..
68:930-934.
1991
-
Relation of clinical and angiographic factors to functional capacity as measured by the Duke Activity Status Index..
68:973-975.
1991
-
Long-term assessment of right ventricular diastolic filling in patients with pulmonic valve stenosis successfully treated in childhood..
68:648-652.
1991
-
Immunosuppressive therapy and lipoprotein abnormalities after cardiac transplantation..
68:389-391.
1991
-
Frequency of low serum high-density lipoprotein cholesterol levels in hospitalized patients with "desirable" total cholesterol levels..
68:187-192.
1991
-
Determinants of one-year outcome from balloon aortic valvuloplasty..
68:75-80.
1991
-
Percutaneous transluminal coronary angioplasty in octogenarians as an effective therapy for angina pectoris..
68:116-119.
1991
-
Effects of hemoperfusion during percutaneous transluminal coronary angioplasty on left ventricular function..
67:1324-1329.
1991
-
Quantification of ST-segment changes during coronary angioplasty in patients with left bundle branch block..
67:1219-1222.
1991
-
Detection of silent myocardial ischemia in diabetes mellitus..
67:1073-1078.
1991
-
Mortality in patients treated with flecainide and encainide for supraventricular arrhythmias..
67:976-980.
1991
-
Prediction of death and myocardial infarction by radionuclide angiocardiography in patients with suspected coronary artery disease..
67:919-926.
1991
-
Comparison of intravascular ultrasound, external ultrasound and digital angiography for evaluation of peripheral artery dimensions and morphology..
67:817-822.
1991
-
Creation of pseudo narrowing during coronary angioplasty..
67:658-659.
1991
-
Effects of exercise training on cardiorespiratory function in men and women older than 60 years of age..
67:633-639.
1991
-
Lidocaine toxicity after subcutaneous infiltration in children undergoing cardiac catheterization..
67:647-648.
1991
-
Pericardial effusion after intravenous recombinant tissue-type plasminogen activator for acute myocardial infarction..
67:496-500.
1991
-
Complete atrioventricular block complicating inferior wall acute myocardial infarction treated with reperfusion therapy. TAMI Study Group..
67:225-230.
1991
-
Adjunctive use of beta-adrenergic blockers, calcium antagonists and other therapies in coronary thrombolysis.
67:25-31.
1991
-
Mechanical failure of a St. Jude Medical prosthesis.
67:906-908.
1991
-
Changes in standard electrocardiographic ST-segment elevation predictive of successful reperfusion in acute myocardial infarction..
66:1407-1411.
1990
-
Transient electrocardiographic changes of elective coronary angioplasty compared with evolutionary changes of subsequent acute myocardial infarction observed with continuous three-lead monitoring..
66:1509-1512.
1990
-
Usefulness of a pericardial friction rub after thrombolytic therapy during acute myocardial infarction in predicting amount of myocardial damage. The TAMI Study Group..
66:1418-1421.
1990
-
Relation of angiographic detected intracoronary thrombus and silent myocardial ischemia in unstable angina pectoris..
66:1381-1382.
1990
-
Simultaneous measurement of myocardial perfusion and ventricular function during exercise from a single injection of technetium-99m sestamibi in coronary artery disease..
66:68E-71E.
1990
-
Selective infusion of thrombolytic therapy in the acute myocardial infarct-related coronary artery as an alternative to rescue percutaneous transluminal coronary angioplasty..
66:1021-1023.
1990
-
Potential role of the tissue renin-angiotensin system in the pathophysiology of congestive heart failure..
66:22D-30D.
1990
-
Two-year outcome after angiographically documented myocardial reperfusion for acute coronary occlusion. Thrombolysis and Angioplasty Study Group..
66:796-801.
1990
-
Early and late changes in left ventricular systolic performance after percutaneous aortic balloon valvuloplasty..
66:327-332.
1990
-
Reduction of myocardial ischemia during percutaneous transluminal coronary angioplasty with oxygenated Fluosol..
66:279-284.
1990
-
Effect of Type A behavior on exercise test outcome in coronary artery disease..
66:179-182.
1990
-
Detection, characterization and functional assessment of reperfused Q-wave acute myocardial infarction by cine magnetic resonance imaging..
66:1-9.
1990
-
Pulsed Doppler evaluation of right ventricular diastolic filling in children with pulmonary valve stenosis before and after balloon valvuloplasty..
66:79-84.
1990
-
Thrombotic and cardiovascular complications related to nonionic contrast media during cardiac catheterization: analysis of 8,517 patients..
65:1481-1484.
1990
-
Changes in left ventricular systolic performance immediately after percutaneous aortic balloon valvuloplasty..
65:1213-1218.
1990
-
Effects of sample volume location, imaging view, heart rate and age on tricuspid velocimetry in normal subjects..
65:1026-1030.
1990
-
Efficacy and tolerance of high-dose intravenous amiodarone for recurrent, refractory ventricular tachycardia..
65:609-614.
1990
-
Results of high dose intravenous urokinase for acute myocardial infarction..
65:124-131.
1990
-
Ten-year results with the St. Jude Medical prosthesis..
65:217-225.
1990
-
The portable programmable microprocessor-driven real-time 12-lead electrocardiographic monitor: a preliminary report of a new device for the noninvasive detection of successful reperfusion or silent coronary reocclusion..
65:143-148.
1990
-
Aerobic exercise reduces levels of cardiovascular and sympathoadrenal responses to mental stress in subjects without prior evidence of myocardial ischemia..
65:93-98.
1990
-
Detection of restenosis after elective percutaneous transluminal coronary angioplasty using the exercise treadmill test..
65:28-34.
1990
-
Failure of balloon aortic valvuloplasty to result in sustained clinical improvement in patients with depressed left ventricular function..
65:72-77.
1990
-
Clinical correlates and prognostic significance of type A behavior and silent myocardial ischemia on the treadmill..
64:1280-1283.
1989
-
Long-term predictors of sudden and low output death in chronic congestive heart failure secondary to coronary artery disease..
64:1344-1348.
1989
-
Severe pulmonary hypertension and cor pulmonale in the acquired immunodeficiency syndrome..
64:1396-1399.
1989
-
Echocardiographic detection and clinical significance of left atrial vegetations in active infective endocarditis..
64:950-952.
1989
-
Echocardiographic detection of pericardiocentesis-induced subepicardial and intramyocardial hematoma..
64:820-821.
1989
-
A brief self-administered questionnaire to determine functional capacity (the Duke Activity Status Index)..
64:651-654.
1989
-
Coronary risk associated with age and sex of parental heart disease in the Framingham Study..
64:555-559.
1989
-
Lovastatin therapy for hypercholesterolemia in cardiac transplant recipients..
64:631-635.
1989
-
Type A behavior and survival: a follow-up study of 1,467 patients with coronary artery disease..
64:427-432.
1989
-
Doppler evaluation of homograft valved conduits in children..
64:354-358.
1989
-
Prevalence of multivalvular regurgitation in athletes..
64:209-212.
1989
-
Reply.
64:256.
1989
-
Doppler left ventricular diastolic filling abnormalities in aortic stenosis and their relation to hemodynamic parameters..
63:1360-1368.
1989
-
Transient alterations of the QRS complex and ST segment during percutaneous transluminal balloon angioplasty of the right and left circumflex coronary arteries..
63:1208-1213.
1989
-
Quantification of aortic regurgitation after balloon aortic valvuloplasty using videodensitometric analysis of digital subtraction aortography..
63:585-588.
1989
-
Long-term follow-up of patients with echocardiographically detected mitral anular calcium and comparison with age- and sex-matched control subjects..
63:465-470.
1989
-
Prediction of early recurrent myocardial ischemia and coronary reocclusion after successful thrombolysis: a qualitative and quantitative angiographic study..
63:423-428.
1989
-
Repeat percutaneous transluminal coronary angioplasty and predictors of recurrent restenosis..
63:409-413.
1989
-
Pulsed Doppler assessment of left ventricular diastolic filling in children with left ventricular outflow obstruction before and after balloon angioplasty..
63:231-236.
1989
-
Relation of atrial natriuretic factor to vasoconstrictor hormones and regional blood flow in congestive heart failure..
63:211-216.
1989
-
Cardiac mapping at Duke Medical Center..
63 Suppl:17F-30F.
1989
-
Intraoperative echocardiography in congenital heart disease surgery: preliminary report on a current study..
63 Suppl:3F-14F.
1989
-
Frequency of hypercholesterolemia after cardiac transplantation..
62:1268-1272.
1988
-
Usefulness of exercise electrocardiography and thallium scintigraphy in unstable angina pectoris in predicting the extent and severity of coronary artery disease..
62:1164-1170.
1988
-
Angiographic morphology in unstable angina pectoris..
62:1024-1027.
1988
-
Transient alterations of the QRS complex and ST segment during percutaneous transluminal balloon angioplasty of the left anterior descending coronary artery..
62:1038-1042.
1988
-
Evaluation of the QRS complex on the standard 12-lead electrocardiogram in normal subjects 70 to 79 years of age..
62:982-985.
1988
-
Cell biology of vascular hypertrophy in systemic hypertension..
62:30G-35G.
1988
-
An explosion of technology..
62:1F-2F.
1988
-
INTERVENTIONAL CARDIAC-CATHETERIZATION AT DUKE-MEDICAL-CENTER.
62:F3-F24.
1988
-
Interventional cardiac catheterization at Duke Medical Center..
62:3F-24F.
1988
-
Contributions of neuroendocrine and local autocrine-paracrine mechanisms to the pathophysiology and pharmacology of congestive heart failure..
62:76E-81E.
1988
-
Comparison of coronary stenosis quantitation results from on-line digital and digitized cine film images..
62:381-386.
1988
-
Reduced thiols and the effect of intravenous nitroglycerin on platelet aggregation..
62:377-380.
1988
-
Clinical behavior of paroxysmal atrial tachycardia..
62:3D-9D.
1988
-
Stability of multilead ST-segment "fingerprints" over time after percutaneous transluminal coronary angioplasty and its usefulness in detecting reocclusion..
61:1232-1237.
1988
-
Perfusion balloon catheter..
61:77G-80G.
1988
-
Correlates of systolic and diastolic blood pressure in men 40 to 59 years of age sampled from United States of America and Union of Soviet Socialist Republics Lipid Research Clinics populations..
61:1071-1075.
1988
-
Identification of high-risk patients with silent myocardial ischemia after percutaneous transluminal coronary angioplasty by multilead monitoring..
61:29F-35F.
1988
-
Comparison of two dose regimens of intravenous tissue plasminogen activator for acute myocardial infarction..
61:723-728.
1988
-
Evaluation of a QRS scoring system for estimating myocardial infarct size. VI: Identification of screening criteria for non-acute myocardial infarcts..
61:729-733.
1988
-
Helicopter transport of patients during acute myocardial infarction..
61:718-722.
1988
-
Prevalence and significance of atrial fibrillation in coronary artery disease (CASS Registry)..
61:714-717.
1988
-
Use of initial ST-segment deviation for prediction of final electrocardiographic size of acute myocardial infarcts..
61:749-753.
1988
-
Adoption of thrombolytic therapy in the management of acute myocardial infarction..
61:510-514.
1988
-
Effect of iron deficiency on tissue oxygen delivery in cyanotic congenital heart disease..
61:605-607.
1988
-
Trends in physician management of uncomplicated acute myocardial infarction, 1970 to 1987..
61:515-518.
1988
-
Randomized trial of prostacyclin infusion in acute myocardial infarction..
61:455-457.
1988
-
Clinical significance of exercise-induced bundle branch block..
61:346-348.
1988
-
Introduction.
61.
1988
-
Comparison of high- and low-intensity exercise training early after acute myocardial infarction..
61:26-30.
1988
-
Epicardial ventricular pacemaker electrode longevity in children..
61:104-106.
1988
-
Interventional Cardiac Catheterization at Duke Medical Center - The Duke Interventional Cardiac Catheterization Program.
62.
1988
-
Limitations of balloon angioplasty: Possible causes of restenosis.
62.
1988
-
New international technology: The autoperfusion balloon catheter.
62.
1988
-
Relation of results of exercise stress tests in young women to phases of the menstrual cycle..
61:197-199.
1988
-
Refining the type A hypothesis: emergence of the hostility complex..
60:27J-32J.
1987
-
Autocrine-paracrine mechanisms of vascular myocytes in systemic hypertension..
60:99I-103I.
1987
-
Dissociation of the prostaglandin and renin angiotensin systems during captopril therapy for chronic congestive heart failure secondary to coronary artery disease..
60:1101-1105.
1987
-
Calcific valvular aortic stenosis with and without mitral anular calcium..
60:865-870.
1987
-
Exercise ventricular function in mitral valve prolapse..
60:941-942.
1987
-
Outcome in suspected acute myocardial infarction with normal or minimally abnormal admission electrocardiographic findings..
60:766-770.
1987
-
Recovery of systolic and diastolic left ventricular function after a 60-second coronary arterial occlusion during percutaneous transluminal coronary angioplasty for angina pectoris..
60:460-466.
1987
-
Variable responses of mitral valve motion and flow in systemic hypertension and in idiopathic dilated cardiomyopathy..
60:363-367.
1987
-
Accuracy of digital angiography for quantitation of normal coronary luminal segments in excised, perfused hearts..
59:1261-1265.
1987
-
Contribution of afterload, hypertrophy and geometry to left ventricular ejection fraction in aortic valve stenosis, pure aortic regurgitation and idiopathic dilated cardiomyopathy..
59:1398-1404.
1987
-
Echocardiographic and electrocardiographic characteristics of patients with hypertrophic cardiomyopathy with and without mitral anular calcium..
59:1428-1430.
1987
-
Junctional tachycardia in infants and children after open heart surgery for congenital heart disease..
59:1216-1218.
1987
-
Rethinking sensitivity and specificity..
59:1195-1198.
1987
-
Safety and efficacy of inferior vena caval occlusion to rapidly alter ventricular loading conditions in idiopathic dilated cardiomyopathy..
59:937-942.
1987
-
Prognostic effect of bundle branch block related to coronary artery bypass grafting..
59:798-803.
1987
-
An unusual variant of familial preexcitation..
59:371-373.
1987
-
A comparative evaluation of hemodynamic and neurohumoral effects of nitroglycerin and nifedipine in congestive heart failure..
59:59B-63B.
1987
-
Implications of local angiotensin production in cardiovascular physiology and pharmacology..
59:59A-65A.
1987
-
Identification of the optimal electrocardiographic leads for detecting acute epicardial injury in acute myocardial infarction..
59:20-23.
1987
-
Prognostic implications of angiographically normal and insignificantly narrowed coronary arteries..
58:1181-1187.
1986
-
Echocardiographic guidance of cardiac catheterization for atrial septal defect in pregnancy..
58:1133-1134.
1986
-
Emergency ventricular pacing from the esophagus in infancy..
58:1105-1106.
1986
-
Medical, psychological and social correlates of work disability among men with coronary artery disease..
58:911-915.
1986
-
Left ventricular structure and function by echocardiography in ultraendurance athletes..
58:805-809.
1986
-
Localization of the site of ventricular premature complexes by radionuclide angiographic phase imaging..
58:503-511.
1986
-
Factors affecting use of the Doppler-determined time from flow onset to maximal pulmonary artery velocity for measurement of pulmonary artery pressure in children..
58:352-356.
1986
-
A simplified method to predict occurrence of complete heart block during acute myocardial infarction..
57:1213-1219.
1986
-
Physiologic basis for the age-related decline in aerobic work capacity..
57:1374-1379.
1986
-
Comparison of nifedipine alone with propranolol alone for stable angina pectoris including hemodynamics at rest and during exercise..
57:1022-1028.
1986
-
Computerized detection of the lactate threshold in coronary artery disease.
57:1088-1091.
1986
-
Noninvasive detection of coronary artery patency using continuous ST-segment monitoring..
57:916-922.
1986
-
Temporary balloon occlusion of the inferior vena cava for immediate reversal of acute pulmonary edema..
57:886-887.
1986
-
Observations on the occurrence of atrial fibrillation in paroxysmal supraventricular tachycardia..
57:571-575.
1986
-
Transluminal catheter reperfusion: a new technique to reestablish blood flow after coronary occlusion during percutaneous transluminal coronary angioplasty..
57:684-686.
1986
-
Cardiac function in alcohol-associated systemic hypertension..
57:227-231.
1986
-
Career choices of 135 cardiology trainees at Duke University Medical Center from 1970 to 1984..
57:313-315.
1986
-
Interatrial shunting in atrial septal aneurysm..
57:310-312.
1986
-
Upright paradoxical posterior wall movement in mitral valve prolapse..
56:804-806.
1985
-
Life adaptation after percutaneous transluminal coronary angioplasty and coronary artery bypass grafting..
56:395-398.
1985
-
Variant angina and spontaneous coronary artery dissection..
56:485-486.
1985
-
Comparison of two-dimensional echocardiographic and angiographic findings in arrhythmogenic right ventricular dysplasia..
55:1506-1508.
1985
-
Diagnostic and prognostic significance of minimally elevated creatine kinase-MB in suspected acute myocardial infarction..
55:1478-1484.
1985
-
Evaluation of a QRS scoring system for estimating myocardial infarct size. V. Specificity and method of application of the complete system..
55:1485-1490.
1985
-
Role of receptor mechanisms in the adaptive response to habitual exercise..
55:68D-73D.
1985
-
Analysis of risk factors for sudden death after acute myocardial infarction..
55:621-622.
1985
-
Early exercise training in patients older than age 65 years compared with that in younger patients after acute myocardial infarction or coronary artery bypass grafting..
55:263-266.
1985
-
Prognostic significance of precordial ST-segment depression during inferior acute myocardial infarction..
55:325-329.
1985
-
Value of radionuclide angiography for predicting specific cardiac events after acute myocardial infarction..
55:318-324.
1985
-
Calcification of the ascending aorta and aortic and mitral valves in Gaucher's disease..
54:1390-1391.
1984
-
Clinical characteristics of patients younger than 60 years with mitral anular calcium: comparison with age- and sex-matched control subjects..
54:1286-1287.
1984
-
Lipomatous hypertrophy of the atrial septum: diagnosis by combined two-dimensional echocardiography and computerized tomography..
54:1156-1157.
1984
-
Prognostic significance of exercise-induced complex ventricular arrhythmias in coronary artery disease with normal and abnormal left ventricular ejection fraction..
54:1136-1138.
1984
-
Extreme hypercalcemia and electrocardiographic changes..
54:674-675.
1984
-
Assessment of regional left ventricular function using gated radionuclide angiography..
54:294-300.
1984
-
"Left main equivalent" coronary artery disease: its clinical presentation and prognostic significance with nonsurgical therapy..
53:1489-1495.
1984
-
Effects of beta 1-selective and nonselective beta-adrenoceptor blockade during exercise conditioning in healthy adults..
53:1656-1661.
1984
-
Procainamide cardioversion of fetal supraventricular tachyarrhythmia..
53:1460-1461.
1984
-
Relation between premature ventricular contraction site of origin (defined by radionuclide phase analysis) and subsequent left ventricular function..
53:1028-1033.
1984
-
Complete heart block in Reiter's syndrome..
53:967-968.
1984
-
Effects of age on radionuclide angiographic detection and quantitation of left-to-right shunts..
53:879-883.
1984
-
Evaluation of a QRS scoring system for estimating myocardial infarct size. IV. Correlation with quantitative anatomic findings for posterolateral infarcts..
53:706-714.
1984
-
Hemodynamic correlates for timing intervals, ejection rate and filling rate derived from the radionuclide angiographic volume curve..
53:567-571.
1984
-
Relation between radionuclide angiographic regional ejection fraction and left ventricular regional ischemia in awake dogs..
53:294-301.
1984
-
Cardiac conduction defects in patients older than 60 years with aortic stenosis with and without mitral anular calcium..
53:169-172.
1984
-
Myocardial depression by anesthetic agents (halothane, enflurane and nitrous oxide): quantitation based on end-systolic pressure-dimension relations..
53:243-247.
1984
-
Out-of-hospital management of cardiac arrest by basic emergency medical technicians..
53:68-70.
1984
-
Prognostic indicators from radionuclide angiography in medically treated patients with coronary artery disease..
53:18-22.
1984
-
Reply.
53:265.
1984
-
Life-table methods for evaluating antiarrhythmic drug efficacy in patients with paroxysmal atrial tachycardia..
52:1007-1012.
1983
-
Relation between QRS changes and left ventricular function after coronary artery bypass grafting..
52:943-949.
1983
-
Long-term ambulatory therapy with prazosin versus placebo for chronic heart failure: relation between clinical response and left ventricular function at rest and during exercise..
52:782-788.
1983
-
An improving prognosis over time in medically treated patients with coronary artery disease..
52:444-448.
1983
-
Amrinone therapy for congestive heart failure in outpatients with idiopathic dilated cardiomyopathy..
52:304-308.
1983
-
Natural history of patients with single-vessel disease suitable for percutaneous transluminal coronary angioplasty..
52:225-229.
1983
-
Physical conditioning and left ventricular performance in the elderly: assessment by radionuclide angiocardiography..
52:359-364.
1983
-
Cardiac arrest in young, ostensibly healthy patients: clinical, hemodynamic, and electrophysiologic findings..
52:65-69.
1983
-
Comparison of high-dose and medium-dose propranolol in the relief of exercise-induced myocardial ischemia..
52:7-13.
1983
-
Effect of atrial fibrillation on atrial blood flow in conscious dogs..
51:1722-1727.
1983
-
Relation of left ventricular mass to geometry of the proximal coronary arteries in the dog..
51:1728-1731.
1983
-
Discriminant function analysis using thallium-201 scintiscans and exercise stress variables to predict coronary heart disease..
51:1565.
1983
-
Clinical and echocardiographic characteristics of patients with mitral anular calcification. Comparison with age- and sex-matched control subjects..
51:992-995.
1983
-
Cardiac rhabdomyosarcoma presenting as hypereosinophilic syndrome..
51:909-910.
1983
-
Clonidine in congestive heart failure: a vasodilator with negative inotropic effects..
51:791-795.
1983
-
Comparative rates of resolution of QRS changes after operative and nonoperative acute myocardial infarcts..
51:378-381.
1983
-
Evaluation of a QRS scoring system for estimating myocardial infarct size. III. Correlation with quantitative anatomic findings for inferior infarcts..
51:382-389.
1983
-
Cryosurgery for cardiac arrhythmias: acute and chronic effects on coronary arteries..
51:149-155.
1983
-
Determinants of variable exercise performance among patients with severe left ventricular dysfunction..
51:52-60.
1983
-
Assessment of the use of the age- and sex-specific United States population as a control group for analysis of survival in coronary artery disease..
50:1279-1282.
1982
-
Prospective evaluation of radionuclide angiocardiography for the diagnosis of coronary artery disease..
50:1212-1216.
1982
-
Anatomic and prognostic implications of an early positive treadmill exercise test..
50:682-688.
1982
-
Onset of atrial fibrillation during antidromic tachycardia: association with sudden cardiac arrest and ventricular fibrillation in a patient with Wolff-Parkinson-White syndrome..
50:353-359.
1982
-
Prognostic implications of ventricular arrhythmias during 24 hour ambulatory monitoring in patients undergoing cardiac catheterization for coronary artery disease..
50:23-31.
1982
-
The spectrum of unstable angina: prognostic role of serum creatine kinase determination..
49:1849-1852.
1982
-
Evaluation of a QRS scoring system for estimating myocardial infarct size. II. Correlation with quantitative anatomic findings for anterior infarcts..
49:1604-1614.
1982
-
The electrophysiologic basis and management of symptomatic recurrent tachycardia in patients with Ebstein's anomaly of the tricuspid valve..
49:1223-1234.
1982
-
Predictors of the ejection fraction response to exercise in patients with coronary artery disease.
49:1002-1002.
1982
-
Survival in single vessel coronary disease.
49:1008-1008.
1982
-
Exercise responses before and after physical conditioning in patients with severely depressed left ventricular function..
49:296-300.
1982
-
Digoxin-induced positive exercise tests: their clinical and prognostic significance..
48:655-659.
1981
-
Mitral valve replacement for isolated mitral regurgitation: analysis of clinical course and late postoperative left ventricular ejection fraction..
48:647-654.
1981
-
Unstable angina pectoris: National Cooperative Study Group to Compare Medical and Surgical Therapy. IV. Results in patients with left descending coronary artery disease..
48:517-524.
1981
-
Absent pulmonary valve syndrome in infancy: surgery reconsidered..
48:117-122.
1981
-
Early changes in left ventricular size and function after correction of left ventricular volume overload..
47:991-1004.
1981
-
Accuracy of radionuclide angiocardiography in the diagnosis of coronary artery disease — A prospective study.
47:444-444.
1981
-
Prognostic significance of left main equivalent stenosis.
47:408-408.
1981
-
Acute effects of ethanol on myocardial blood flow in the nonischemic and ischemic heart..
47:61-67.
1981
-
Cardiac function during rest and exercise in patients with mitral valve prolapse. Role of radionuclear angiocardiography..
47:14-19.
1981
-
Digitalis and exercise testing, a five year followup.
47:416.
1981
-
The effect of verapamil on the diastolic mechanics of the left ventricle.
47:411.
1981
-
The effects of moderate and high dose propranolol on ventricular function in patients with coronary artery disease.
47:430.
1981
-
Evaluation of the left ventricle with two dimensional echocardiography..
46:1117-1124.
1980
-
Two dimensional echocardiography in mitral, aortic and tricuspid valve prolapse. The clinical problem, cardiac nuclear imaging considerations and a proposed standard for diagnosis..
46:1164-1177.
1980
-
Comparison of multigated radionuclide angiography with ultrasonic sonomicrometry over a wide range of ventricular function in the conscious dog..
46:976-982.
1980
-
Nonfatal myocardial infarction in medically treated patients with coronary artery disease..
46:937-942.
1980
-
Pharmacokinetic-hemodynamic studies of nitroglycerin ointment in congestive heart failure..
46:670-676.
1980
-
Effect of brief and prolonged exercise on left ventricular function..
45:1154-1160.
1980
-
"Harvey," the cardiology patient simulator: pilot studies on teaching effectiveness..
45:791-796.
1980
-
Unstable angina pectoris: national cooperative study group to compare surgical and medical therapy. III. Results in patients with S-T segment elevation during pain..
45:819-824.
1980
-
Effects of exercise training on left ventricular function in normal subjects: a longitudinal study by radionuclide angiography..
45:244-252.
1980
-
Left bundle branch block: angiographic segmental wall motion abnormalities..
44:1046-1049.
1979
-
Effects of antihypertensive therapy on cardiovascular response to exercise.
44:325-328.
1979
-
Effect of oxygen on ischemic myocardial blood flow.
43:391.
1979
-
Influence of experimental myocardial ischemia on beta adrenergic receptors.
43:395.
1979
-
The influence of pH on the electrophysiological effects of lidocaine in guinea pig ventricular myocardium.
43:375.
1979
-
Unstable angina pectoris: National Cooperative Study Group to Compare Surgical and Medical Therapy..
42:839-848.
1978
-
Detection of tricuspid regurgitation with contrast two-dimensional echocardiography.
41:371-371.
1978
-
ALPHA-ADRENERGIC RECEPTORS IN RAT MYOCARDIUM - DIRECT IDENTIFICATION BY BINDING OF [H-3]DIHYDROERGOCRYPTINE.
41:970-970.
1978
-
Reply.
42:1061.
1978
-
The quest for optimal electrocardiography. Tast Force I: standardization of terminology and interpretation..
41:130-145.
1978
-
Effects of propranolol on the hemodynamic, coronary sinus blood flow and myocardial metabolic response to atrial pacing..
40:83-89.
1977
-
Cardiac arrest complicating acute myocardial infarction: predictability and prognosis..
39:7-12.
1977
-
Echocardiographic evaluation of tricuspid valve endocarditis: an M mode and two dimensional study..
38:502-507.
1976
-
Nitroglycerin ointment in acute myocardial infarction..
38:474-478.
1976
-
Editorial: Diagnostic considerations in electromechanical dissociation..
38:268-269.
1976
-
Spectrum of coronary artery disease in idiopathic hypertrophic subaortic stenosis..
38:12-16.
1976
-
Aortocoronary bypass surgery: Correlation of angiographic symptomatic and functional improvement at 1 year..
37:352-357.
1976
-
Effect of nitroglycerin ointment on the clinical and hemodynamic response to exercise.
38:162-166.
1976
-
Reply-I.
38:135.
1976
-
Reply-II.
38:136-137.
1976
-
Reply-III.
38:137.
1976
-
Mahaim and James fibers as a basis for a unique variety of ventricular preexcitation..
36:880-888.
1975
-
Hereditary progressive atrioventricular conduction defect..
36:297-301.
1975
-
Significant sex differences in the correlation of electrocardiographic exercise testing and coronary arteriograms..
36:169-173.
1975
-
Ventricular aneurysm with ventricular tachycardia. Report of a case with epicardial mapping and successful resection..
35:696-700.
1975
-
Vectorcardiographic diagnosis of anterior myocardial infarction.
35:170-170.
1975
-
Ischemic cardiomyopathy: the myopathy of coronary artery disease. Natural history and results of medical versus surgical treatment..
34:520-525.
1974
-
Reply.
34:746-747.
1974
-
Clinical implications of pulmonary hypertension in mitral stenosis..
32:650-655.
1973
-
Apex cardiogram in patients with prolapsing mitral valve..
32:276-282.
1973
-
Effect of different epicardial ventricular pacing sites on left ventricular function in awake dogs..
32:291-294.
1973
-
Pulmonary wedge catheter..
31:405-407.
1973
-
Quantitative radionuclide angiocardiography for determination of chamber to chamber cardiac transit times..
30:855-864.
1972
-
Spread of excitation from the atrium into thoracic veins in human beings and dogs..
30:844-854.
1972
-
Assessment of ventricular function in coronary artery disease by means of atrial pacing and exercise..
26:107-116.
1970
-
Kerley B lines in total anomalous pulmonaru venous connection below the diaphragm (type 3)..
24:436-440.
1969
-
Immediate hemodynamic effects of acute coronary occlusion and their modification by anesthesia..
22:559-567.
1968
-
Pressure and volume changes of the left ventricle in acute pericardial tamponade..
22:65-74.
1968
-
The ballooning mitral valve in patients with the "precordial honk" or "whoop"..
20:789-795.
1967
-
Mechanisms of action of morphine in the treatment of experimental pulmonary edema..
18:876-883.
1966
-
Determination of leakage currents in medical equipment..
17:437-438.
1966
-
HAZARDS OF ELECTRIC SHOCK IN CARDIOLOGY..
14:537-546.
1964
-
LEFT AXIS DEVIATION..
14:330-338.
1964
-
Derivation and Validation of a Risk Model for Predicting Clinically-Driven Target Lesion Revascularization in Drug Eluting Stents
2009
-
Increase in The Nationwide Utilization of Percutaneous Coronary Intervention (PCI) in Patients With Diabetes, Congestive Heart Failure, ST Elevation and Non ST Elevation Myocardial Infarction in the United State
2009
-
Persistent Decline in The Nationwide Trends from Percutaneous Coronary Intervention (PCI) Related Mortality in Patients with Diabetes, Congestive Heart Failure, ST Elevation And Non ST Elevation Myocardial Infarction in The United State
2009
-
Retrograde Ascending Aortic Dissection During or After Thoracic Aortic Stent-Graft Placement-Insights from the European Registry on Endovascular Aortic Repair Complications (EuREC)
2009
-
Aortoesophageal Fistula after Thoracic Aortic Stent-Graft Placement: A Rare But Catastrophic Complication of Novel Emerging Technique
2008
-
Gene Expression in Peripheral Blood Reflects the Presence and Extent of Coronary Artery Stenosis
2008
-
Near-infrared Spectroscopic Measurement of Lipid-Core Coronary Plaque Length: Implications for Complete Lesion Coverage in Patients Undergoing Stenting
2008
-
Relationship of the Near Infrared Lipid Core Burden Index in Coronary Segments with Traditional Risk Factors in Patients Undergoing PCI
2008
-
Comparison of outcomes between patients undergoing percutaneous coronary stent implantation with eptifibatide and abciximab: An analysis using propensity score methods
2007
-
Detection of lipid rich plaque by near-infrared spectroscopy (NIRS) in patients undergoing coronary intervention: Results in an unblinded cohort of the SPECTrospic assessment of coronary lipid (SPECTACL) study
2007
-
Impact of thienopyridine administration prior to primary stealing in acute myocardial infarction
2007
-
Incidence and predictors of bleeding among patients undergoing rescue percutaneous coronary intervention after failed fibrinolysis for ST-elevation myocardial infarction
2007
-
Significant reverse remodeling of the left ventricle one year after percutaneous mitral repair with the MitraClip (TM) device
2007
-
Temporal improvements in door-to-balloon times for primary percutaneous coronary intervention_results from the CRUSADE and ACTION registries
2007
-
ASSENT-4 in "French" perspective. Outcomes of STEMI patients treated with pre-hospital thrombolysis in mobile intensive care units in France across trials and registries
2006
-
Local platelet glycoprotein IIb/IIIa receptor occupancy with intracoronary eptitibatide during stenting, the ICE pilot trial
2006
-
Outcomes in elderly patients undergoing PCI treated with bivalirudin monotherapy versus glycoprotein IIb/IIIa inhibitors with hepaiin or LMWH: Results from the randomized ACUITY trial
2006
-
Overlapping paclitaxel elating stents: Early outcomes in the COSTAR II study
2006
-
Anemic patients undergoing percutaneous coronary intervention have a higher mortality even in the absence of major bleeding complications
2005
-
Cardiac MRI predicts functional improvement in patients undergoing percutaneous revascularization of chronically occluded vessels
2005
-
Impact of baseline platelet count on outcomes of patients undergoing primary percutaneous coronary intervention for acute myocardial infarction: Analysis from the CADILLAC trial
2005
-
Adverse impact of multivessel disease on ST-segment recovery and clinical outcome in patients undergoing primary percutaneous coronary intervention for acute myocardial infarction.
2004
-
Implications of stroke after primary angioplasty in acute myocardial infarction.
2004
-
Outcomes of percutaneous coronary intervention in patients with acute myocardial infarction excluded from randomization: The CADILLAC Trial.
2004
-
Prediction of survival after primary percutaneous coronary intervention by integration of ST-segment recovery and myocardial blush.
2004
-
Prevalence, impact, and predictors of insignificant coronary artery disease in patients with non-ST-segment elevation acute coronary syndromes who undergo angiography: Results from the CRUSADE initiative
2004
-
Reperfusion success and prognosis in patients with anterior compared with nonanterior infarction: Insights from the CADILLAC trial.
2004
-
Activated clotting time values measured with the actalyke machine are consistently lower than measurements obtained with the Hemochron-801
2003
-
Anemia worsens prognosis after primary Angioplasty in acute myocardial infarction: Analysis from the cadillac study
2003
-
Are there any angiographic predictors of abciximab benefit after primary angioplasty for acute myocardial infarction? Analysis from the CADILLAC trial
2003
-
Can stents and glycoprotein IIb/IIIa inhibitors improve the prognosis of young patients with acute myocardial infarction? A report from the controlled abciximab and device investigation to lower late angioplasty complications (CADILLAC) study
2003
-
Does stenting and glycoprotein IIb/IIIa receptor blockade improve ST segment recovery and outcome in patients undergoing primary angioplasty in acute myocardial infarction? The CADILLAC trial
2003
-
Does the use of heparin after primary angioplasty for acute myocardial infarction in patients not receiving glycoprotein IIb/IIIa antagonists alleviate recurrent cardiac ischemia? Insights from the CADILLAC study
2003
-
Does treatment with abciximab influence survival in patients with acute myocardial infarction and elevated baseline white blood cell count undergoing primary angioplasty? The CADILLAC trial
2003
-
Impact of age on the outcomes of women with acute myocardial infarction undergoing primary coronary stenting
2003
-
Impact of myocardial blush analysis methodologies in predicting short and long-term mortality after primary angioplasty. The CADILLAC trial
2003
-
Incidence and implications of in-hospital acquired thromhocytopenia in patients undergoing primary angioplasty for acute myocardial infarction
2003
-
Reduction of ischemic injury following coronary intervention: Results of the MC-1 to eliminate necrosis and damage trial (MEND-1)
2003
-
The survival benefit of periprocedural beta-blockers in patients with acute myocardial infarction undergoing primary angioplasty is determined by use of these drugs before admission
2003
-
Treating patients with non-ST-elevation acute coronary syndromes with aggressive antiplatelet agents in the GRACE registry: No observed improvement in hospital outcomes
2003
-
Early results of minimally invasive mitral valve operation using an endoaortic balloon clamp catheter
1997
-
Regional electrophysiologic and rheologic effects of endocardial cryoablation
1982
-
Effects of cardioplegic infusion rate and topical hypothermia on elective cardiac arrest
1982